US20070129788A1 - Venous valve with sinus - Google Patents

Venous valve with sinus Download PDF

Info

Publication number
US20070129788A1
US20070129788A1 US11/652,299 US65229907A US2007129788A1 US 20070129788 A1 US20070129788 A1 US 20070129788A1 US 65229907 A US65229907 A US 65229907A US 2007129788 A1 US2007129788 A1 US 2007129788A1
Authority
US
United States
Prior art keywords
valve
sectional area
cross sectional
inlet
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/652,299
Inventor
William Drasler
Mark Jenson
Jason Hill
David Sogard
Patrick Haverkost
Susan Shoemaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/232,403 priority Critical patent/US7569071B2/en
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US11/652,299 priority patent/US20070129788A1/en
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DRASLER, WILLIAM J., JENSON, MARK L., SOGARD, DAVID J., HAVERKOST, PATRICK A., SHOEMAKER, SUSAN M., HILL, JASON P.
Publication of US20070129788A1 publication Critical patent/US20070129788A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2475Venous valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
    • A61F2/2427Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436Deployment by retracting a sheath
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0008Fixation appliances for connecting prostheses to the body
    • A61F2220/0016Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0066Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49405Valve or choke making

Abstract

A venous valve-with a structural member and valve leaflets that provide a sinus.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a Continuation-in Part of U.S. application Ser. No. 11/232,403, filed Sep. 21, 2005, the specification of which is incorporated by reference herein.
  • FIELD OF THE DISCLOSURE
  • The present disclosure relates to vascular medical devices and methods; and more particularly to venous valves and methods for forming the venous valve frame.
  • BACKGROUND OF THE DISCLOSURE
  • Venous blood flow returns de-oxygenated blood from the distal extremities to the heart via two mechanisms. The first is the perfusion pressure resulting from the arterial blood flow through tissue to the venous circulation system. Where arterial pressure prior to perfusion may be 60 to 200 mm Hg, the resulting venous pressure is typically 10 to 40 mm Hg. The second mechanism is the calf muscle, which, when contracted, compresses the veins (tibial and peroneal) overlying the bone and, through a system of valves, directs blood flow toward the heart. This is the organized flow of blood through a normal, healthy person.
  • Venous valves, especially those in the upper leg, perform an important function. When a person rises from a seated to a standing position, arterial blood pressure increases instantaneously to insure adequate perfusion to the brain and other critical organs. In the legs and arms, the transit time of this increased arterial pressure is delayed, resulting in a temporary drop in venous pressure. Venous pressure drops as blood flow responds to body position change and gravity, thereby reducing the volume of blood available to the heart and possibly reducing the flow of oxygenated blood to the brain. In such a case, a person could become light headed, dizzy, or experience syncope. It is the function of valves in the iliac, femoral and, to a lesser degree, more distal vein valves to detect these drops in pressure and resulting change of direction of blood flow and to close to prevent blood from pooling in the legs to maintain blood volume in the heart and head. The valves reopen and the system returns to normal forward flow when the reflected arterial pressure again appears in the venous circulation. Compromised valves, however, would allow reverse blood flow and pooling in the lower legs resulting in swelling and ulcers of the leg. The absence of functioning venous valves can lead to chronic venous insufficiency.
  • Techniques for both repairing and replacing the valves exist, but are tedious and require invasive surgical procedures. Direct and indirect valvuoplasty procedures are used to repair damaged valves. Transposition and transplantation are used to replace an incompetent valve. Transposition involves moving a vein with an incompetent valve to a site with a competent valve. Transplantation replaces an incompetent valve with a harvested valve from another venous site.
  • Prosthetic valves can be transplanted into the venous system, but current devices are not successful enough to see widespread usage. One reason for this is the very high percentage of prosthetic valves reported with leaflet functional failures due to excessive protein deposit, cell growth and thickening, and thrombosis. These failures have been blamed primarily on improper sizing and tilted deployment of the prosthetic valve. In addition, a great number of the valve leaflets come into close proximity to or in contact with the adjacent vessel wall, conduit, or supporting frame of the valve. Such contact or proximity can cause regions of blood stasis or near stasis, and can result in increased thrombus formation. In addition, contact can result in disruption of endothelial or other tissue at the contact point, further increasing the likelihood of thrombosis or increased tissue deposits or healing response. Further, such contact or proximity can result in valve leaflet(s) being stuck to the vessel wall, or otherwise unable to move properly, thereby rendering the valve less functional or completely non-functional.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates the venous valve of the present disclosure.
  • FIG. 2 illustrates an elevation view of a section of the venous valve illustrated in FIG. 1.
  • FIG. 3 illustrates a plan view of a section of the venous valve, specifically the bottom half of the venous valve illustrated in FIG. 1.
  • DETAILED DESCRIPTION
  • Embodiments of the present disclosure are directed to vascular medical devices and methods for valve replacement and/or augmentation. Particularly, the present disclosure provides venous valves and methods for forming the venous valve. Various embodiments of the present disclosure can be used to replace and/or augment an incompetent valve in a body lumen. As used herein, “body lumen” can include, but is not limited to, veins, arteries, lymph vessels, ureter, cerebrospinal fluid track, or other body cavity, vessel, or duct.
  • Embodiments of the venous valve include a venous valve frame and valve leaflets that can be implanted through minimally-invasive techniques into the body lumen. In one example, embodiments of the apparatus and method for valve replacement or augmentation may help to maintain antegrade blood flow, while decreasing retrograde blood flow in a venous system of individuals having venous insufficiency, such as venous insufficiency in the legs. Use of valve embodiments can also be possible in other portions of the vasculature.
  • The figures herein follow a numbering convention in which the first digit or digits correspond to the drawing figure number and the remaining digits identify an element or component in the drawing. Similar elements or components between different figures may be identified by the use of similar digits. For example, 110 may reference element “10” in FIG. 1, and a similar element may be referenced as 210 in FIG. 2. As will be appreciated, elements shown in the various embodiments herein can be added, exchanged, and/or eliminated so as to provide a number of additional embodiments of valve. In addition, discussion of features and/or attributes for an element with respect to one Figure can also apply to the element shown in one or more additional Figures. Embodiments illustrated in the figures are not necessarily to scale.
  • FIG. 1 provides an illustration of various embodiments of a venous valve 100 of the present disclosure. The venous valve 100 can be implanted within the fluid passageway of a body lumen, such as for replacement and/or augmentation of a valve structure within the body lumen (e.g., a venous valve). In one embodiment, the venous valve 100 of the present disclosure may be beneficial to regulate the flow of a bodily fluid through the body lumen in a single direction.
  • FIG. 1 provides a top view of the venous valve 100 with a frame 102 being generally shown as a tubular body. While frame 102 is shown as a tubular body for illustrative purposes, the present disclosure contemplates that the frame 102 can have a number of different structural configurations that will be more fully discussed herein.
  • The frame 102 can have an inlet region 104 that defines an inlet cross sectional area 106, a middle region 108 that defines a middle cross sectional area 110, and an outlet region 112 that defines an outlet cross sectional area 114. As will be more fully discussed herein, various embodiments provide that the inlet cross-sectional area 106 can have a different relative size than the middle cross sectional area 110. In addition, the inlet cross sectional area 106 can be at least approximately equal to the outlet cross sectional area 114. Other relative relationships, as discussed herein, are also possible.
  • The venous valve 100 also includes valve leaflets 116 at least partially connected to the frame 102. The valve leaflets 116 include a first inflow surface 118, a first outflow surface 120 opposite the first inflow surface 118 and a free edge 122. In one embodiment, the valve leaflets 116 are configured to shift between an open position, shown with a broken line 124 in FIG. 1, and a closed position, shown with a solid line 126. The free edge 122 of the valve leaflet 116 helps define a free edge cross sectional area 128.
  • The material of the valve leaflets 116 can be connected to the frame 102 in a variety of ways so as to provide the various embodiments of the venous valve 100 of the present disclosure. For example, a variety of fasteners can be used to couple the material of the valve leaflets 116 to the frame 102 so as to form the venous valve 100. Suitable fasteners can include, but are not limited to, biocompatible staples, glues, sutures, or combinations thereof. In an additional embodiment, the material of the valve leaflets 116 can be coupled to the frame 102 through the use of heat sealing, solvent bonding, adhesive bonding, or welding the material of the valve leaflets 116 to either a portion of the valve leaflets 116 (i.e., itself) and/or the frame 102.
  • As illustrated in FIG. 1, the valve leaflets 116 can be coupled to at least a portion of the valve frame 102. As illustrated, the valve leaflets 116 can move relative the valve frame 102. The valve leaflets 116 can be unbound (i.e., unsupported) by the frame 102 and can extend between opposite sides of the frame 102 in the middle region 108. This configuration permits the valve leaflets 116 to move (e.g., pivot) relative the opposite sides of the frame 102 in the middle region 108 to allow a commissure 129 to reversibly open and close for unidirectional flow of the liquid through the venous valve 100.
  • Valve 100 provides an embodiment in which the surfaces defining the commissure 129 provide a bi-leaflet configuration (i.e., a bicuspid valve) for valve 100. Although the embodiments in FIG. 1 illustrate and describe a bi-leaflet configuration for the valve of the present disclosure, designs employing a different number of valve leaflets (e.g., tri-leaflet valve) may be possible. For example, additional connection points (e.g., three or more) could be used to provide additional valve leaflets (e.g., a tri-leaflet valve).
  • In addition, embodiments of the present disclosure couple the valve leaflets 116 to the frame 102 in a way such that the valve leaflets 116 in the closed position 126 form a fluid tight commissure 129.
  • The relationship between the valve leaflets 116 and the frame 102 also help to define a sinus region 130. As illustrated, the sinus region 130 can be defined by a volume 132 between the frame 102 and the valve leaflets 116 extending from an attachment location 134 to the free edge 122 while in the open position.
  • In one embodiment, the sinus region 130 can perform a variety of functions for the venous valve 100. For example, the sinus region 130 can allow for blood moving through the venous valve 100 to backwash into and through the sinus region 130. While not wishing to be bound by theory, the formation of the backwash into and through the sinus region 130 is a result of a separation of the blood flow as it moves past the free edge 122 of the valve leaflets 116. Separation occurs due to the extreme change in cross sectional area as the blood emerges from the free edge cross-sectional area 128 into the area defined by the middle cross-section 110. This separation forms eddy currents 136 that wash back into the sinus region 130 keeping both constant blood flow through the sinus region 130 and separating the valve leaflets 116 from the frame 102 and the native vessel wall. This latter feature helps to minimize the likelihood that the valve leaflets 116 will adhere to the frame 102 and/or any of the native vessel wall in which the venous valve 100 is placed.
  • The sinus region 130 also allows for improved valve leaflet 116 dynamics (e.g., opening and closing of the valve leaflets). For example, the sinus region 130 can allow for pressure differentials across the surfaces of the valve leaflets 116 that provide for more rapid closing of the valve leaflets 116 as the retrograde blood flow begins, as will be discussed herein.
  • As discussed herein, the presence of the sinus region 130 allows slower moving blood (e.g., backwash) to move into the sinus region 130 and faster moving blood on the first inflow surface 118 to create a pressure differential. This pressure differential across the valve leaflets 116 provides for a Bernoulli effect. The Bernoulli principle provides that the sum of all forms of energy in a fluid flowing along an enclosed path (e.g., the venous valve 100 positioned within a vein) is the same at any two points in that path. As discussed herein, the velocity of blood flow across the first inflow surface 118 of the valve leaflets 116 is greater than the velocity of blood flow across the outflow surface 120 of the valve leaflets 116. The result is a larger fluid pressure on the outflow surface 120 as compared to the first inflow surface 118. So, when blood flow slows through the valve, the fluid pressure on the first outflow surface 120 becomes larger than the fluid pressure on the first inflow surface 118 and the valve leaflets 116 have a natural tendency to “shut.”
  • The valve leaflets 116 of the present disclosure are also configured to include a complex curvature which can be utilized to form a pocket when the venous valve 100 is in the closed position. The pocket is shaped synergistically to enhance the performance of the venous valve 100 with the sinus region 130, as discussed herein. As used herein, “pocket” means a portion of the valve leaflet 116 that is concave when in the closed position 126 and distends when in the open position 124.
  • In one embodiment, the free edge 122 of the valve leaflets 116 can be positioned at a predetermined location 138 along the middle region 108 of the frame 102. For example, the predetermined location 138 can be positioned approximately at the maximum dimension of the middle cross section 110. Other predetermined locations 138 include those in the middle region 108 that are closer to the inlet region 104 than the outlet region 112. Other predetermined locations 138 are also possible, as will be discussed herein. In addition, specific dimensional relationships for the valve leaflets 116 and the middle region 108 of the frame 102 exist. These relationships will be discussed more fully herein.
  • According to the present disclosure, there are a variety of relative sizes for the inlet region 104, the middle region 108, and the outlet region 112 in association with the valve leaflets 116 that can provide for the backwash function of the sinus region 130. For example, as illustrated in FIG. 1, the inlet cross-sectional area 106, the free edge cross-sectional area 128 of the valve leaflets 116 in their open position, and the outlet cross-sectional area 114 all have approximately the same cross sectional area, whereas the middle cross-sectional area 110 has a larger relative cross sectional area. For example, in one embodiment, the relative diameters of the inlet region 104, middle region 108, and outlet region 112 are approximately equal to 1.0, 1.8, and 1.1, respectively. So, as blood flows past the free edge 122 of the valve leaflets 116, the blood flow separates, forming eddy currents 136 that provide at least in part, the backwash in the sinus region 130.
  • In an alternative embodiment, other configurations of the comparative sizes of the inlet, middle, free edge, and outlet cross-sectional areas 106, 110, 128, and 114 are possible that can provide for the backwash function of the sinus region 130. For example, both the middle and outlet cross-sectional areas 110, 114 can be larger than both the inlet cross-sectional area 106 and the free edge cross-sectional area 128 in its open position. In an alternative embodiment, the middle cross-sectional area 110 and the free edge cross-sectional area 128 in its open position can be smaller than both the inlet and the outlet cross-sectional areas 106, 114. In yet another embodiment, the free edge cross-sectional area 128 in its open position is smaller than both the middle and outlet cross-sectional areas 110, 114 while both the middle and outlet cross-sectional areas 110, 114 are smaller than the inlet cross-sectional area 106.
  • In the embodiments where the free edge cross-sectional area 128 in its open position is smaller than the inlet cross-sectional area 106, the Bernoulli principle, as discussed herein, provides that the fluid velocity increases as a result of the decrease in cross-sectional area. In these embodiments, the resulting increase in fluid velocity can provide enhanced recirculation and less thrombosis throughout the venous valve 100 due to increased blood flow velocity that effectively “flushes” thrombus and/or other material through and out of the venous valve 100. Additionally, in embodiments where the middle cross-sectional area 110 is smaller than the body lumen and the free edge cross-sectional area 128 in its open position is smaller than the inlet cross-sectional area 106, an increase in fluid velocity may help to “draw in” the tissue of the native vessel wall, creating a more fluid tight position for the venous valve 100 of the present disclosure. On the other hand, in these embodiments a prosthetic material can be provided to the treatment site to create a narrowing where the middle cross-sectional area 128 is to be positioned.
  • The free edge 122 of the valve leaflets 116 in their open configuration can define a number of different shapes, including round and non-round shapes. For example, the free edge 122 can define an eye shape or an oval shape. As will be appreciated, other shapes for the valve leaflets 116 in their open configuration are also possible.
  • In addition, the valve leaflets 116 are illustrated as being essentially of the same size and relative shape. This allows for a symmetrical configuration for the valve leaflets 116. Alternatively, the valve leaflets 116 can have a non-symmetrical configuration, where one of the valve leaflets 116 has at least one of a different size and/or shape as compared to another of the valve leaflets 116.
  • As illustrated, the frame 102 is shown having a circular peripheral shape. Other peripheral shapes for the frame 102 are possible. For example, peripheral shapes for the frame 102 can include not only circular, but elliptical, obround, conical, semi-conical, semi-spherical, polygonal, or combinations thereof. In one embodiment, polygonal shapes can include those defined generally with the struts to form, for example, triangular, tetragon (e.g., square or rectangular), pentagon, hexagon, and heptagon, among other polygonal shapes. Different combinations of these shapes for different regions 104, 108 and 112 are also possible.
  • Although the frame 102 can have many peripheral shapes including polygonal shapes, the functional shape of the frame 102 may change over time. For example, once the venous valve 100 is inserted into a body vessel, the body vessel wall will begin to form tissue deposits as it heals in and around the venous valve 100. As this occurs, the polygonal shape of the frame 102 may functionally change into more of a circular shape. Embodiments of the present disclosure take this process into account however, and remain functional despite potential in growth into the venous valve 100.
  • There are many ways in which the frame 102 may be formed. Generally, the frame 102 includes structural members 140 that define openings through the frame 102. One embodiment of the structural members 140 are shown partially in FIG. 1 forming the outlet region 112. As discussed herein, the frame 102 is shown as a tubular body for illustrative purposes; in addition, the structural members 140 as shown in the outlet region 112 are for illustrative purposes and are not meant to limit the configuration of the frame formed by the structural members 140.
  • In one embodiment, the structural members 140 of frame 102 are formed by cutting the openings in a contiguous tube of material to form the inlet, the middle, and the outlet regions 104, 108, 112 of the frame 102. Examples of techniques for cutting include laser cutting and/or water jet cutting. Other cutting techniques are also possible.
  • Different shapes and sizes for the regions 104, 108, and 112 can then be formed by stretching and/or deforming the structural members 140 to the desired shape and size. In one embodiment, the frame 102 can be positioned over a mandrel that defines the desired shape of the frame 102. Once positioned, the structural members 140 of the frame 102 can then be bent to conform to the shape of the mandrel. Alternatively, the structural members 140 of the frame 102 can be wound around the mandrel to form the desired configuration. The structural member 140 can then be processed according to the material type used. For example, the structural member 140 can be heat set on the mandrel to set the shape according to techniques as are known.
  • In an alternative embodiment, different portions of the frame 102 can be formed separately and then joined to form the frame 102. When the different regions are formed separately, the two portions can be joined by a welding technique, such as laser welding. Other welding or bonding techniques are also possible.
  • In one embodiment, the structural members 140 of the frame 102 are designed to provide a distribution of forces along the length of the frame 102. For example, the structural members 140 in the middle region 108 can be designed to provide an expansion force greater than the inlet and outlet regions 104, 112. The distribution of forces can be accomplished in various ways, including changing the spacing between the structural members 140 in the different regions (e.g., the inlet region 104, etc.), changing the number of structural members 140 in the different regions, by heat setting the structural members 140, or by changing the shape of the frame 102 in the different regions, among others.
  • As will be appreciated, differing cross-sectional shapes for the structural members 140 are possible, including but not limited to round (e.g., circular, oval, and/or elliptical), rectangular geometries having perpendicular sides, one or more convex sides, or one or more concave sides; semi-circular; triangular; tubular; I-shaped; T-shaped; and trapezoidal. The similarity and/or differences in the cross-sectional geometries and/or cross-sectional dimensions can be based on one or more desired functions to be elicited from each portion of the structural member 140.
  • As discussed, natural venous valves partially function via contraction of the calf muscles which compress the veins overlying the bones and direct blood flow toward the heart. Embodiments of the present disclosure, therefore, can be designed to either resist collapsing under the contraction of the muscle, or embodiments can be designed to collapse in a predetermined way while maintaining functionality, as further discussed herein.
  • In one embodiment, the frame 102 is designed to resist collapsing by providing a sufficient number of structural members 140 in a predetermined configuration so as to resist the prevailing radial pressures. By maintaining a relatively static configuration, the relationship between the valve leaflets 116 and the different regions (e.g., the inlet region 104, the middle region 108, etc.) Is controlled. Controlling the relationship between the valve leaflets 116 and the different regions (e.g., the inlet region 104, the middle region 108, etc.) Allows the valve leaflets 116 to operate more effectively. For example, by controlling the relationship of the valve leaflets 116 and the different regions (e.g., the inlet region 104, etc.) The size of the valve leaflets 116 can be minimized, thus decreasing the chance that a valve leaflet 116 will come into contact with the frame 102 and/or the native vessel wall.
  • In an alternative embodiment, the frame 102 can be configured to radially collapse at least partially when the calf muscle contracts over the vein. In one embodiment, the structural members 140 of the frame 102 can be configured to collapse in a predetermined direction so that the valve leaflets 116 are able to shift from the open position to the closed position as illustrated in FIG. 1 when the frame 102 is collapsed. For example, the structural members 140 of the frame 102 can be configured so that when the calf muscle contracts, some of the structural members 140 collapse radially inward in the middle region 108 to compress the sinus region 130. At the same time, other structural members 140 in the middle region 108 radially extend outward so that the attachment locations 134 at the free edges 122 of the valve leaflets 116 are stretched apart. Other configurations are also possible including structural members 140 collapsing in other regions of the frame 102 (e.g., inlet region 104 and outlet region 112) either in combination with the middle region 108 or alone.
  • The embodiments of the structural member 140 described herein can also be constructed of one or more of a number of materials and in a variety of configurations. The structural member 140 embodiments can have a unitary structure with an open frame configuration. The structural member 140 can also be self-expanding. Examples of self-expanding frames include those formed from temperature-sensitive memory alloy which changes shape at a designated temperature or temperature range, such as Nitinol. Alternatively, the self-expanding structural members 140 can include those having a spring-bias. In addition, the structural member 140 can have a configuration that allows the structural member 140 embodiments be radially expandable through the use of a balloon catheter.
  • The structural member 140 can be formed from a number of materials. For example, the structural member 140 can be formed from a biocompatible metal, metal alloy, polymeric material, or combination thereof. As described herein, the structural member 140 can be self-expanding or balloon expandable. In addition, as discussed herein, the structural member 140 can be configured so as to have the ability to move radially between the collapsed state and the expanded state. Examples of suitable materials include, but are not limited to, medical grade stainless steel (e.g., 316L), titanium, tantalum, platinum alloys, niobium alloys, cobalt alloys, alginate, or combinations thereof. Additional structural member 140 embodiments may be formed from a shape-memory material, such as shape memory plastics, polymers, and thermoplastic materials. Shape memory alloys having superelastic properties generally made from ratios of nickel and titanium, commonly known as Nitinol, are also possible materials. Other materials are also possible.
  • The venous valve 100 can further include one or more radiopaque markers (e.g., rivets, tabs, sleeves, welds). For example, one or more portions of the structural member can be formed from a radiopaque material. Radiopaque markers can be attached to, electroplated, dipped and/or coated onto one or more locations along the frame. Examples of radiopaque material include, but are not limited to, gold, tantalum, and platinum.
  • The position of the one or more radiopaque markers can be selected so as to provide information on the position, location, and orientation (e.g., axial, directional, and/or clocking position) of the valve 100 during its implantation. For example, radiopaque markers can be configured radially and longitudinally (e.g., around and along portions of the structural member 140) on predetermined portions of the structural member 140 to allow the radial and axial position of the structural member 140 to be determined. So in one embodiment a radiograph image of the structural member 140 taken perpendicular to the valve leaflets 116 in a first clock position can produce a first predetermined radiograph image (e.g., an imaging having the appearance of an inverted “Y”) and a radiographic image taken perpendicular to the commissure 129 in a second clock position can produce a second predetermined radiograph image (e.g., an imaging having the appearance of an upright “Y”) distinguishable from the first predetermined radiograph image.
  • FIG. 2 is an illustration of a portion of the venous valve cut along the longitudinal center axis 2-2 in FIG. 1 to show one valve leaflet 216 connected to the frame 202 in the open position, as discussed herein. As illustrated, the frame 202 provides for a longitudinal center axis 242 extending from the inlet region 204 to the outlet region 212. The longitudinal center axis 242 provides a reference point to assist in the definition of various features of the valve leaflets 216 in relation to the frame 202 in different regions of the valve (e.g., inlet region 204, middle region 208, etc.).
  • As discussed herein, the free edge 222 of the valve leaflets 216 can be positioned at a predetermined location 238 along the middle region 208 of the frame 202. For example, as discussed herein, the predetermined location 238 can be positioned approximately at the maximum dimension of the middle cross-sectional area 210. In an additional embodiment, the predetermined location 238 can be positioned at a distance of at least twenty-five (25) percent from the inlet region 204 along the longitudinal center axis 242. For example, the predetermined location 238 can be positioned at a distance ranging from fifty (50) percent from the inlet region 204 to eighty (80) percent from the inlet region 204 along the longitudinal center axis 242. In addition, the predetermined location 238 can be positioned at a distance approximately eighty-five (85) percent from the inlet region 204 along the longitudinal center axis 242. The predetermined location 238 can also be positioned at a distance of greater than one hundred (100) percent from the inlet region 204 along the longitudinal center axis 242. In this embodiment, however, the valve leaflet 216 material must be chosen to resist thrombosis if it comes into contact with the frame 202 or the native vessel wall, as discussed more fully herein. Further, as the predetermined location 238 moves farther from the inlet region 204, the volume 232 of the sinus region 230 decreases, which may affect the backwash, as discussed herein.
  • The valve leaflet 216 of the present disclosure can be formed of various fluid impermeable, biocompatible materials including synthetic materials or biologic materials. Examples of synthetic materials include, but are not limited to: polyisobutylene-polystyrene (SIBS), polyurethane, poly(dimethylsiloxane) (PDMS), flouropolymer, proteins, polyethylene terephthalate (PET), protein analogs, copolymers of at least one of these materials, and other biologically stable and tissue-compatible materials as are known in the art. The materials may be formed by spinning, weaving, winding, solvent-forming, thermal forming, chemical forming, deposition, and combinations, include porous coatings, castings, moldings, felts, melds, foams, fibers, microparticles, agglomerations, and combinations thereof.
  • Possible biologic materials include, but are not limited to, autologous, allogeneic, or xenographt material. These include explanted veins and decellularized basement membrane materials (such as non-crosslinked bladder membrane or amnionic membrane), such as small intestine submucosa (SIS) or umbilical vein. As will be appreciated, blends or mixtures of two or more of the materials provided herein are possible. For example, SIBS could be blended with one or more basement membrane materials.
  • A material for the valve leaflets 216 can also include a fluid permeable open woven, or knit, physical configuration to allow for tissue in-growth and stabilization, and can have a fluid impermeable physical configuration.
  • The valve leaflets 216 may also be reinforced with high-strength materials. Examples of high-strength materials are nitinol, stainless steel, titanium, algiloy, elgiloy, carbon, cobalt chromium, other metals or alloys, PET, expanded polytetrafluoroethylene (ePTFE), polyimide, surlyn, and other materials known in the art. The high-strength materials may be in the form of wires, meshes, screens, weaves, braids, windings, coatings, or a combination. The high strength materials may be fabricated by methods such as drawing, winding, braiding, weaving, mechanical cutting, electrical discharge machining (EDM), thermal forming, chemical vapor deposition (CVD), laser cutting, e-beam cutting, chemical forming, and other processes known in the art. One embodiment includes CVD nitinol and wound or braided nitinol.
  • Suitable bioactive agents which may be incorporated with or utilized together with the valve leaflets 216 may be selected from silver antimicrobial agents, metallic antimicrobial materials, growth factors, cellular migration agents, cellular proliferation agents, anti-coagulant substances, stenosis inhibitors, thrombo-resistant agents, growth hormones, antiviral agents, anti-angiogenic agents, agents, growth hormones, antiviral agents, anti-tumor agents, angiogenic agents, anti-mitotic agents, anti-inflammatory agents, cell cycle regulating agents, genetic agents, cholesterol lowering agents, vasodilating agents, agents that interfere with endogenous vasoactive mechanisms, and hormones, their homologs, derivatives, fragments, pharmaceutical salts thereof, and combinations thereof. Specific examples are discussed herein.
  • Suitable bioactive agents which may be incorporated with or utilized together with the valve leaflets 216 can also include diagnostic agents or media such as radiologic contrast materials, MRI contrast agents, ultrasound contrast agents, or other imaging aids such as iodinated or non-iodinated contrast media, metallic materials such as gold, iridium, platinum, palladium, barium compounds, gadolinium, encapsulated gas, or silica.
  • Suitable biologically active materials are those than reduce tissue migration, proliferation, and hyperplacia, and include, but are not limited to, the following: paclitaxel, taxotere, rapamycin, sirolimus, and everolimus. Examples of resorbable materials include gelatin, alginate, PGA, PLLA, collagen, fibrin and other proteins. Examples of leakage-reducing materials include ePTFE, hydrophobic coatings, and bioresorbable layers. Materials such as elastin, acellular matrix proteins, decellularized small intestinal submucosa (SIS), and protein analogs, and certain polymers such as PTFE can perform multiple functions such as providing microporous material, leakage-reducing function, bioresorption, and/or facilitation of elution of biologically active material.
  • To decrease the risk of thrombosis, thrombo-resistant agents associated with the valve leaflets 216 may be selected from the following agents: heparin, heparin sulfate, hirudin, hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, PPack (dextrophenylalanine proline arginine chloromethylketone), lytic agents, including urokinase and streptokinase, including their homologs, analogs, fragments, derivatives and pharmaceutical salts thereof.
  • Also, anti-coagulants may be selected from the following: D-Phe-Pro-Arg chloromethyl ketone, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, anti-platelet receptor antibodies, aspirin, prostaglandin inhibitors, platelet inhibitors, tick antiplatelet peptides and combinations thereof.
  • In addition, suitable antibiotic agents include, but are not limited to, the following agents: penicillins, cephalosporins, vancomycins,aminoglycosides, quinolones, polymyxins, erythromycins, tetracyclines, chloramphenicols, clindamycins, lincomycins, sulfonamides, their homologs, analogs, derivatives, pharmaceutical salts and combinations thereof.
  • Anti-proliferative agents include, but are not limited to, the following: enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, acetylsalicylic acid, and combinations thereof.
  • Useful vascular cell growth inhibitors include, but are not limited to, the following: growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin.
  • Suitable vascular cell growth promoters include, but are not limited to, transcriptional activators and transcriptional promoters.
  • Useful anti-tumor agents include, but are not limited to, the following: paclitaxel, docetaxel, taxotere, alkylating agents including mechlorethamine, chlorambucil, cyclophosphamide, melphalan and ifosfamide, antimetabolites including methotrexate, 6-mercaptopurine, 5-fluorouracil and cytarabine, plant alkaloids. including vinblastine, vincristine and etoposide, antibiotics including doxorubicin, daunomycin, bleomycin, and mitomycin, nitrosureas including carmustine and lomustine, inorganic ions including cisplatin, biological response modifiers including interferon, angiostatin agents and endostatin agents, enzymes including asparaginase, and hormones including tamoxifen and flutamide, their homologs, analogs, fragments, derivatives, pharmaceutical salts and combinations thereof.
  • Furthermore, anti-viral agents include, but are not limited to, amantadines, rimantadines, ribavirins, idoxuridines, vidarabines, trifluridines, acyclovirs, ganciclovirs, zidovudines, foscarnets, interferons, their homologs, analogs, fragments, derivatives, pharmaceutical salts and mixtures thereof.
  • Useful anti-inflammatory agents include agents such as: dexametbasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, mesalamine, and combinations thereof.
  • In one embodiment, an anti-mitotic agent may be radioactive material coupled to a biologically compatible carrier. In particular, the radioactive material may be selected from alpha-particle emitting isotopes and beta-particle emitting isotopes. Useful beta-particle emitting isotopes for treatment are generally selected from 32P, 131I, 90Y and mixtures thereof.
  • In other embodiments, the bioactive agent(s) associated with the valve leaflet 216 of the present disclosure may be a genetic agent. Examples of genetic agents include DNA, anti-sense DNA, and anti-sense RNA. DNA encoding one of the following may be particularly useful in association with an implantable device according to the present invention: (a) tRNA or rRNA to replace defective or deficient endogenous molecules; (b) angiogenic factors including growth factors such as acidic and basic fibroblast growth factors, vascular endothelial growth factor, epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, platelet-derived endothelial growth factor, platelet-derived growth factor, tumor necrosis factor alpha, hepatocyte growth factor and insulin-like growth factor; (c) cell cycle inhibitors; (d) thymidine kinase and other agents useful for interfering with cell proliferation; and (e) the family of bone morphogenic proteins. Moreover DNA encoding for molecules capable of inducing an upstream or downstream effect of a bone morphogenic protein may be useful.
  • The valve leaflets 216 may also be treated and/or coated with any number of surface or material treatments. For example, the valve leaflets 216 can be treated with one or more biologically active compounds and/or materials that may promote and/or inhibit endothelization and/or smooth muscle cell growth of the valve leaflets 216. Examples of such coatings include, but are not limited to, polyglactic acid, poly-L-lactic acid, glycol-compounds, and lipid compounds. Additionally, coatings can include medications, genetic agents, chemical agents, and/or other materials and additives. In addition, agents that limit or decrease cellular proliferation can be useful. Similarly, the valve leaflets 216 may be seeded and covered with cultured tissue cells (e.g., endothelial cells) derived from a either a donor or the host patient which are attached to the valve leaflets 216. The cultured tissue cells may be initially positioned to extend either partially or fully over the valve leaflets 216.
  • Valve leaflets 216 can also be capable of inhibiting thrombus formation. Additionally, valve leaflets 216 may either prevent or facilitate tissue in growth there through, as the particular application for the valve 200 may dictate. For example, valve leaflets 216 on the first outflow surface 220 may be formed from a porous material to facilitate tissue in growth there through, while valve leaflets 216 on the first inflow surface 218 may be formed from a material or a treated material which inhibits tissue ingrowth.
  • In one embodiment, the valve leaflet 216 material chosen can have some dependency on the configuration of the frame 202. As discussed herein, the frame 202 can be designed to resist collapsing under contraction of the calf muscle. In this embodiment, the material of the valve leaflet 216 can be non-elastic since the frame 202 in the middle region 208 remains approximately the same shape. However, in embodiments where the frame 202 is designed to collapse in a predetermined way under contraction of the muscle, the valve leaflet 216 can be an elastic material so that the valve leaflet 216 attachment locations 238 remain intact while the valve leaflet 216 maintains the ability to shift from the open position to the closed position, as discussed herein. In other embodiments, the elasticity of the valve leaflet 216 material can be dependent on the flexibility of the frame 202.
  • In an additional embodiment, the material of the valve leaflets 216 can be sufficiently thin and pliable so as to permit radially-collapsing of the valve leaflets 216 for delivery by catheter to a location within a body lumen, as discussed herein.
  • FIG. 2 also illustrates the venous valve 200 of the present disclosure where the valve leaflet 216 has a valve leaflet length 244 and a valve leaflet width 246. The valve leaflet width 246 can be measured between two predetermined locations 238 of the free edge 222 on a plane 248 extending perpendicularly from the longitudinal center axis 242 where the distance is greatest. The valve leaflet length 244 can be measured along the inflow surface 218 where the distance between the free edge 222 and an attachment location 234 of the valve leaflet 216 is greatest. The valve leaflet length 244 will be discussed more fully herein. In one embodiment, the valve leaflets 216 can have a ratio of valve leaflet length 244 to valve leaflet width 246. For example, the ratio of valve leaflet length 244 to valve leaflet width 246 can range from 0.75:1 to 1.5:1. In another embodiment, the ratio of valve leaflet length 244 to valve leaflet width 246 can be greater than 1.5:1. In an additional embodiment, the ratio of valve leaflet length 244 to valve leaflet width 246 can be less than 0.75:1.
  • FIG. 3 is an illustration of a portion of the venous valve 300 cut along the longitudinal center axis 3-3 in FIG. 1 to show the valve leaflets 316 connected to the frame 302 in the open position, as discussed herein. As discussed herein, specific dimensional relationships for the valve leaflets 316 and the middle region 308 of the frame 302 exist. For example, as illustrated, the valve leaflets 316 in their open configuration define a gap 350 between the free edge 322 of the valve leaflets 316 and the middle region 308 of the frame 302. The gap 350 is measured perpendicular to the longitudinal center axis 342, and in one embodiment, can have a maximum distance from the free edge 322 of the valve leaflets 316 to the middle region 308 of the frame 302 ranging from 0.5 millimeters (mm) to four (4) mm. In an additional embodiment, the gap 350 can have a maximum distance ranging from one (1) to three (3) mm. In yet another embodiment, the gap can have a maximum distance ranging from 1.5 to 2.5 mm. In addition, the distance of the gap 350 between each valve leaflet 316 and the frame 302 can be, but is not necessarily, equal.
  • In addition to the described maximum distance range of the gap 350, the gap 350 can also be dependent on the inlet diameter 352 of the inlet cross-sectional area 306. In one embodiment, the inlet cross-sectional area 306 can range from six (6) to eighteen (18) millimeters (mm). In an additional embodiment, the inlet cross-sectional area 306 can range from eight (8) to fifteen (15) mm. In yet another embodiment, the inlet cross-sectional area 306 can range from eight (8) to twelve (12) mm.
  • As discussed herein, the valve leaflets have a first inflow surface 318 and a first outflow surface 320 opposite the inflow surface 318. In addition, as discussed herein, the valve leaflets 316 have a valve leaflet length 344. The valve leaflet length 344 is measured along the inflow surface 318 of the valve leaflet 316 where the distance between the free edge 322 and an attachment location 134 to the frame 302 perpendicular to the free edge 322 in the middle region 308 is greatest. In one embodiment, the valve leaflet length 344 can be configured so that, in the closed position, approximately twenty (20) percent of the inflow surface 318 of the valve leaflets 316 overlap to form a fluid tight commissure.
  • In one embodiment, the valve leaflet length 344 (L) is be a function of the inlet radius 354 (ri) of the inlet cross-sectional area 306, and can be at least equal to the inlet radius 354 (ri). In another embodiment, the valve leaflet length 344 (L) is a function of the inlet radius 354 (ri), where the function can range from L=1.2ri to L=8ri. In an additional embodiment, the valve leaflet length 375 (L) is a function of the inlet radius 354 (ri), where the function can range from L=1.5ri to L=5ri.
  • As will be understood by those skilled in the art, the valve 300 can be placed within a body lumen of the venous system by introducing a catheter into the venous system of the patient using a minimally invasive percutaneous, transluminal catheter based delivery system, as is known in the art. For example, a guidewire can be positioned within a body lumen of a patient that includes the predetermined location. The catheter, including valve 300, as described herein, can be positioned over the guidewire and the catheter advanced so as to position the valve 300 at or adjacent a predetermined location.
  • Although specific details regarding embodiments of the venous valve 300 have been discussed in relation to the venous valve 300 itself, embodiments of the present disclosure can also vary in relation to the size of the body lumen in which the valve 300 is to be placed. For example, in one embodiment, the middle cross-sectional area 310 can be larger than the body lumen cross sectional area and the inlet and outlet cross sectional-areas 306, 314 are approximately equal to the body lumen cross-sectional area. In this embodiment, the middle region 308 will expand the body lumen. In an additional embodiment, the inlet, middle, and outlet cross-sectional areas 306, 310, 314 can be smaller than the body lumen cross-sectional area. Different combinations of cross-sectional area sizes (e.g., inlet cross-sectional area 306, etc.) with respect to the body lumen are also possible.
  • The venous valve 300 of the present disclosure has been shown and described in detail including three regions, the inlet region 304, the middle region 308, and the outlet region 312. Additional embodiments of the present disclosure also include a venous valve 300 with less than three regions. For example, in one embodiment, the frame 302 can be designed to include an inlet region 304 and a middle region 308 such that the middle cross-sectional area 310 is larger than the inlet cross-sectional area 306. In this embodiment, the middle cross-sectional area 310 may be larger than the body lumen cross-sectional area and the inlet cross-sectional area 306 can be approximately equal to the body lumen cross-sectional area, and the valve leaflets 316 extend effectively from the middle region 308 into the body lumen. Other embodiments with more than three regions are also possible.
  • In addition, different combinations of cross-sectional area sizes (e.g., inlet cross-sectional area 306) with respect to the body lumen are also possible. Further, different combinations of cross-sectional area sizes (e.g., inlet cross-sectional area 306, etc.) with respect to other regions in the venous valve 300 are also possible.
  • While the present disclosure has been shown and described in detail above, it will be clear to the person skilled in the art that changes and modifications may be made without departing from the scope of the disclosure. As such, that which is set forth in the foregoing description and accompanying drawings is offered by way of illustration only and not as a limitation. The actual scope of the disclosure is intended to be defined by the following claims, along with the full range of equivalents to which such claims are entitled.
  • In addition, one of ordinary skill in the art will appreciate upon reading and understanding this disclosure that other variations for the disclosure described herein can be included within the scope of the present disclosure. For example, the frame 302 and/or the valve leaflets 316 can be coated with a non-thrombogenic biocompatible material, as are known or will be known.
  • In the foregoing Detailed Description, various features are grouped together in several embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the embodiments of the disclosure require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separate embodiment.

Claims (25)

1. A venous valve, comprising:
a structural member having an inlet region that defines an inlet cross sectional area, a middle region that defines a middle cross sectional area, and an outlet region that defines an outlet cross sectional area, the inlet cross sectional area being different than the middle cross sectional area, and the inlet cross sectional area being at least approximately equal to the outlet cross sectional area;
a first valve leaflet connected to the structural member, the first valve leaflet including a first inflow surface and a first outflow surface opposite the first inflow surface, and being configured to shift between an open position and a closed position; and
a sinus defined by a volume between the structural member at the middle cross sectional area and the first outflow surface of the first valve leaflet in the open position.
2. The venous valve of claim 1, including a second valve leaflet connected to the structural member opposite the first valve leaflet, where the first valve leaflet and the second valve leaflet have free edges in the sinus that in the open position form a free edge cross sectional area.
3. The venous valve of claim 2, where the inlet cross sectional area is approximately equal to the outlet cross sectional area, is greater than the free edge cross sectional area, and is less than the middle cross sectional area.
4. The venous valve of claim 2, where the middle cross sectional area is greater than the inlet cross sectional area and is approximately equal to the outlet cross sectional area and the inlet cross sectional area is greater than the free edge cross sectional area.
5. The venous valve of claim 2, where the inlet cross sectional area is approximately equal to both the free edge cross sectional area and the outlet cross sectional area, and the inlet cross sectional area is less than the middle cross sectional area.
6. The venous valve of claim 2, where the inlet cross sectional area is approximately equal to the outlet cross sectional area, the inlet cross sectional area is greater than the middle cross sectional area, and the middle cross sectional area is greater than the free edge cross sectional area.
7. The venous valve of claim 2, where the structural member provides for a longitudinal center axis extending from the inlet region to the outlet region, the free edge of the first and second valve leaflet extending from an attachment location on the structural member at a distance at least twenty-five (25) percent from the inlet region along the longitudinal center axis.
8. The venous valve of claim 7, where the attachment location on the structural member ranges from a distance fifty (50) percent from the inlet region to eighty (80) percent from the inlet region along the longitudinal center axis.
9. The venous valve of claim 2, where the structural member provides for a longitudinal center axis, where the free edge of the first or second valve leaflet in the open position and the middle region of the structural member define a gap having a maximum distance ranging from 0.5 to four (4) millimeters (mm) measured perpendicular to the longitudinal center axis.
10. The venous valve of claim 9, where the gap has a maximum distance ranging from one (1) to three (3) mm.
11. The venous valve of claim 10, where the maximum distance ranges from 1.5 to 2.5 mm.
12. The venous valve of claim 2, where the first and second valve leaflets have a valve leaflet length (L) along the inflow surface measured at a greatest length distance between the free edge and an attachment location to the structural member perpendicular to the free edge, where the inlet cross sectional area has an inlet radius (ri), and where the valve leaflet length (L) is a function of the inlet radius (ri) and is at least approximately equal to the inlet radius (ri).
13. The venous valve of claim 12, where the valve leaflet length (L) is a function of the inlet radius (ri) that ranges from L=1.2ri to L=8ri.
14. The venous valve of claim 13, where the function ranges from L=1.5ri to L=5ri.
15. The venous valve of claim 2, where the structural member provides for a longitudinal center axis, where the first and second valve leaflets have a valve leaflet width (W) measured at a greatest width distance between attachment locations to the structural member existing on a plane extending perpendicularly from the longitudinal center axis, and where the first and second valve leaflets have a valve leaflet length (L) along the inflow surface measured at a greatest length distance between the free edge and an attachment location to the structural member perpendicular to the free edge, and the ratio of valve leaflet length (L) to the valve leaflet width (W) ranges from 0.75:1 to 1.5:1.
16. The venous valve of claim 15, where the ratio of valve leaflet length (L) to valve leaflet width (W) is between 0.75:1 and 1.5:1.
17. The venous valve of claim 1, where the first valve leaflet is formed of a material selected from the group comprising urinary bladder matrix (UBM), expanded polytetrafluoroethylene (ePTFE), polyurethane, silicone, polystyrene, and a cellurized tissue from a human, an animal, or a plant source.
18. The venous valve of claim 16, where the material is reinforced with a metal mesh.
19. A method, comprising:
forming a middle region in a venous valve frame with an inlet region and a outlet region, the middle region being substantially different than the inlet region, and the inlet region being at least approximately equal to the outlet region; and
coupling valve leaflets to the venous valve frame, where a free edge of the valve leaflets are located adjacent the middle region to form a sinus between the middle region in the venous valve frame and the valve leaflets.
20. The method of claim 19, including configuring an opening defined by the valve leaflet to create a Bernoulli effect across the valve leaflet.
21. The method of claim 19, where coupling the valve leaflet to the venous valve frame includes providing a gap of at least a predetermined distance between the free edge of the valve leaflet and the middle region in the venous valve frame.
22. The method of claim 21, where coupling the valve leaflet to the venous valve frame includes maintaining at least the gap between the free edge of the valve leaflet and the middle region in the venous valve frame as the valve leaflet cycles between an open position and a closed position.
23. The method of claim 19, where the venous valve frame resists flexing and can withstand a high expansion force on the middle region and a low expansion force on the inlet region and outlet region.
24. The method of claim 19, where the venous valve frame is flexible and the valve leaflet is made of an elastomeric material.
25. The method of claim 19, where the venous valve frame is flexible and the valve leaflet is large enough to maintain the closed position when the venous valve frame is compressed.
US11/652,299 2005-09-21 2007-01-11 Venous valve with sinus Abandoned US20070129788A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/232,403 US7569071B2 (en) 2005-09-21 2005-09-21 Venous valve, system, and method with sinus pocket
US11/652,299 US20070129788A1 (en) 2005-09-21 2007-01-11 Venous valve with sinus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/652,299 US20070129788A1 (en) 2005-09-21 2007-01-11 Venous valve with sinus
US13/454,778 US8672997B2 (en) 2005-09-21 2012-04-24 Valve with sinus

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/232,403 Continuation-In-Part US7569071B2 (en) 2005-09-21 2005-09-21 Venous valve, system, and method with sinus pocket

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/454,778 Continuation US8672997B2 (en) 2005-09-21 2012-04-24 Valve with sinus

Publications (1)

Publication Number Publication Date
US20070129788A1 true US20070129788A1 (en) 2007-06-07

Family

ID=37885235

Family Applications (8)

Application Number Title Priority Date Filing Date
US11/232,403 Active 2026-08-02 US7569071B2 (en) 2005-09-21 2005-09-21 Venous valve, system, and method with sinus pocket
US11/652,299 Abandoned US20070129788A1 (en) 2005-09-21 2007-01-11 Venous valve with sinus
US12/509,604 Active 2025-09-22 US7951189B2 (en) 2005-09-21 2009-07-27 Venous valve, system, and method with sinus pocket
US13/117,770 Active 2026-02-05 US8460365B2 (en) 2005-09-21 2011-05-27 Venous valve, system, and method with sinus pocket
US13/454,778 Active US8672997B2 (en) 2005-09-21 2012-04-24 Valve with sinus
US13/913,830 Abandoned US20130274865A1 (en) 2005-09-21 2013-06-10 Venous Valve, System, and Method With Sinus Pocket
US14/877,182 Active US9474609B2 (en) 2005-09-21 2015-10-07 Venous valve, system, and method with sinus pocket
US15/286,025 Pending US20170020672A1 (en) 2005-09-21 2016-10-05 Venous valve, system, and method with sinus pocket

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/232,403 Active 2026-08-02 US7569071B2 (en) 2005-09-21 2005-09-21 Venous valve, system, and method with sinus pocket

Family Applications After (6)

Application Number Title Priority Date Filing Date
US12/509,604 Active 2025-09-22 US7951189B2 (en) 2005-09-21 2009-07-27 Venous valve, system, and method with sinus pocket
US13/117,770 Active 2026-02-05 US8460365B2 (en) 2005-09-21 2011-05-27 Venous valve, system, and method with sinus pocket
US13/454,778 Active US8672997B2 (en) 2005-09-21 2012-04-24 Valve with sinus
US13/913,830 Abandoned US20130274865A1 (en) 2005-09-21 2013-06-10 Venous Valve, System, and Method With Sinus Pocket
US14/877,182 Active US9474609B2 (en) 2005-09-21 2015-10-07 Venous valve, system, and method with sinus pocket
US15/286,025 Pending US20170020672A1 (en) 2005-09-21 2016-10-05 Venous valve, system, and method with sinus pocket

Country Status (4)

Country Link
US (8) US7569071B2 (en)
EP (1) EP1945141B1 (en)
CA (1) CA2623321C (en)
WO (1) WO2007038047A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060259115A1 (en) * 2005-05-13 2006-11-16 Case Brian C Medical device delivery systems that facilitate medical device placement in the presence of ultrasonic waves
US20060271064A1 (en) * 2005-05-24 2006-11-30 Agnew Charles W Medical device delivery system with captive inner member
US20070167745A1 (en) * 2005-12-29 2007-07-19 Cook Incorporated Methods for delivering medical devices to a target implant site within a body vessel
US20070288087A1 (en) * 2006-05-30 2007-12-13 Cook Incorporated Artificial valve prosthesis
US20090248142A1 (en) * 2008-03-25 2009-10-01 Medtronic Vascular, Inc. Methods, Devices and Systems for Treating Venous Insufficiency
US20100217385A1 (en) * 2009-02-24 2010-08-26 Medtronic Vascular, Inc. One-Way Replacement Valve
US20110033933A1 (en) * 2009-07-15 2011-02-10 Morteza Gharib Method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves
WO2012015825A3 (en) * 2010-07-27 2012-04-19 Incept, Llc Methods and apparatus for treating neurovascular venous outflow obstruction
US20170156863A1 (en) * 2015-12-03 2017-06-08 Medtronic Vascular, Inc. Venous valve prostheses

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498604B2 (en) 1997-11-12 2016-11-22 Genesis Technologies Llc Medical device and method
WO2004030568A2 (en) * 2002-10-01 2004-04-15 Ample Medical, Inc. Device and method for repairing a native heart valve leaflet
US7959666B2 (en) * 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa cardiac valve prosthesis
AU2005221234C1 (en) 2004-03-11 2009-10-29 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous heart valve prosthesis
US7744642B2 (en) * 2004-11-19 2010-06-29 Biomedical Research Associates, Inc. Prosthetic venous valves
ITTO20050074A1 (en) 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl Prosthetic heart valve
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US8092520B2 (en) 2005-11-10 2012-01-10 CardiAQ Technologies, Inc. Vascular prosthesis connecting stent
WO2007075892A2 (en) * 2005-12-23 2007-07-05 Clinasys Llc An implantable prosthetic valve
US8403977B2 (en) 2006-05-04 2013-03-26 Cook Medical Technologies Llc Self-orienting delivery system
ES2441801T3 (en) 2007-02-05 2014-02-06 Boston Scientific Limited Percutaneous valve and delivery system
US9415567B2 (en) * 2007-02-05 2016-08-16 Boston Scientific Scimed, Inc. Synthetic composite structures
US7753949B2 (en) * 2007-02-23 2010-07-13 The Trustees Of The University Of Pennsylvania Valve prosthesis systems and methods
US20080208327A1 (en) * 2007-02-27 2008-08-28 Rowe Stanton J Method and apparatus for replacing a prosthetic valve
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
US20090105813A1 (en) * 2007-10-17 2009-04-23 Sean Chambers Implantable valve device
EP2222247B1 (en) * 2007-11-19 2012-08-22 Cook Medical Technologies LLC Valve frame
US8057532B2 (en) * 2007-11-28 2011-11-15 Cook Medical Technologies Llc Implantable frame and valve design
MX2010008171A (en) 2008-01-24 2010-12-07 Medtronic Inc Stents for prosthetic heart valves.
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
WO2010011878A2 (en) * 2008-07-24 2010-01-28 Cook Incorporated Valve device with biased leaflets
CN102292053A (en) 2008-09-29 2011-12-21 卡迪尔克阀门技术公司 Heart valve
WO2010040009A1 (en) 2008-10-01 2010-04-08 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US8834563B2 (en) 2008-12-23 2014-09-16 Sorin Group Italia S.R.L. Expandable prosthetic valve having anchoring appendages
EP2405863A1 (en) 2009-02-24 2012-01-18 Cook Incorporated Low profile support frame and related intraluminal medical devices
GB0905444D0 (en) * 2009-03-30 2009-05-13 Ucl Business Plc Heart valve prosthesis
JP2012523894A (en) 2009-04-15 2012-10-11 カルディアック バルブ テクノロジーズ,インコーポレーテッド Vascular implants and arranged system
EP2628465A1 (en) 2009-04-27 2013-08-21 Sorin Group Italia S.r.l. Prosthetic vascular conduit
US20130096692A1 (en) * 2009-08-14 2013-04-18 Mayo Foundation For Medical Education And Research Non-circular esophageal stents and delivery systems
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US9561094B2 (en) 2010-07-23 2017-02-07 Nfinium Vascular Technologies, Llc Devices and methods for treating venous diseases
IT1400327B1 (en) 2010-05-21 2013-05-24 Sorin Biomedica Cardio Srl Support device for valve prostheses and corresponding kit.
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
WO2012054776A1 (en) * 2010-10-21 2012-04-26 Medtronic Inc Mitral bioprosthesis with low ventricular profile
ES2641902T3 (en) 2011-02-14 2017-11-14 Sorin Group Italia S.R.L. Anchoring device for sutureless heart valve prostheses
EP2486894A1 (en) 2011-02-14 2012-08-15 Sorin Biomedica Cardio S.r.l. Sutureless anchoring device for cardiac valve prostheses
AU2012290221B2 (en) * 2011-07-29 2017-02-23 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
EP2842517A1 (en) 2011-12-29 2015-03-04 Sorin Group Italia S.r.l. A kit for implanting prosthetic vascular conduits
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US9597205B2 (en) 2012-06-06 2017-03-21 Magenta Medical Ltd. Prosthetic renal valve
US9883941B2 (en) 2012-06-19 2018-02-06 Boston Scientific Scimed, Inc. Replacement heart valve
EP2874568B1 (en) 2012-07-20 2018-01-10 Cook Medical Technologies LLC Implantable medical device having a sleeve
CA2905349A1 (en) 2013-03-13 2014-09-18 Magenta Medical Ltd. Renal pump
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9681186B2 (en) 2013-06-11 2017-06-13 Nokia Technologies Oy Method, apparatus and computer program product for gathering and presenting emotional response to an event
US8870948B1 (en) 2013-07-17 2014-10-28 Cephea Valve Technologies, Inc. System and method for cardiac valve repair and replacement
US9764113B2 (en) 2013-12-11 2017-09-19 Magenta Medical Ltd Curved catheter
US10143544B2 (en) 2014-08-29 2018-12-04 Cook Medical Technologies Llc Low profile intraluminal medical devices
US10010399B2 (en) 2014-08-29 2018-07-03 Cook Medical Technologies Llc Low profile intraluminal filters
US9974651B2 (en) 2015-02-05 2018-05-22 Mitral Tech Ltd. Prosthetic valve with axially-sliding frames
WO2016183526A1 (en) 2015-05-14 2016-11-17 Cephea Valve Technologies, Inc. Replacement mitral valves
KR20180067537A (en) * 2015-10-13 2018-06-20 베나룸 메디컬, 엘엘씨 Implantable valve and method
US20170196686A1 (en) * 2016-01-07 2017-07-13 Medtronic Vascular, Inc. Bioprosthetic tissue repair and reinforcement
US10098740B2 (en) 2016-07-15 2018-10-16 Covidien Lp Venous valve prostheses
USD800908S1 (en) 2016-08-10 2017-10-24 Mitraltech Ltd. Prosthetic valve element
US20190038404A1 (en) 2017-08-03 2019-02-07 Cardiovalve Ltd. Prosthetic Heart Valve

Citations (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994077A (en) * 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US5713953A (en) * 1991-05-24 1998-02-03 Sorin Biomedica Cardio S.P.A. Cardiac valve prosthesis particularly for replacement of the aortic valve
US5716370A (en) * 1996-02-23 1998-02-10 Williamson, Iv; Warren Means for replacing a heart valve in a minimally invasive manner
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US20020013571A1 (en) * 1999-04-09 2002-01-31 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US20020026216A1 (en) * 1999-10-13 2002-02-28 Grimes Randall Y. Devices and methods for percutaneous mitral valve repair
US6503272B2 (en) * 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US6508833B2 (en) * 1998-06-02 2003-01-21 Cook Incorporated Multiple-sided intraluminal medical device
US20040002719A1 (en) * 1997-06-27 2004-01-01 Oz Mehmet C. Method and apparatus for circulatory valve repair
US6673109B2 (en) * 1993-11-01 2004-01-06 3F Therapeutics, Inc. Replacement atrioventricular heart valve
US20040003819A1 (en) * 1999-04-09 2004-01-08 Evalve, Inc. Methods and apparatus for cardiac valve repair
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US6676702B2 (en) * 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US20040010305A1 (en) * 2001-12-05 2004-01-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040015232A1 (en) * 2002-07-16 2004-01-22 Medtronic, Inc. Suturing rings for implantable heart valve prosthesis
US20040015230A1 (en) * 1996-12-18 2004-01-22 Moll Franciscus Laurens Methods for regulating the flow of blood through the blood system
US20040015233A1 (en) * 2000-10-09 2004-01-22 Josef Jansen Cardiac valve prosthesis, especially mitral cardiac valve and method for producing the same
US6682559B2 (en) * 2000-01-27 2004-01-27 3F Therapeutics, Inc. Prosthetic heart valve
US6682558B2 (en) * 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US20040019374A1 (en) * 2002-05-10 2004-01-29 Hikmat Hojeibane Frame based unidirectional flow prosthetic implant
US20040019377A1 (en) * 2002-01-14 2004-01-29 Taylor Daniel C. Method and apparatus for reducing mitral regurgitation
US20040019378A1 (en) * 2001-04-24 2004-01-29 Hlavka Edwin J. Method and apparatus for performing catheter-based annuloplasty
US6685739B2 (en) * 1999-10-21 2004-02-03 Scimed Life Systems, Inc. Implantable prosthetic valve
US20040024451A1 (en) * 2002-01-02 2004-02-05 Medtronic, Inc. Prosthetic heart valve system
US20040024452A1 (en) * 2002-08-02 2004-02-05 Kruse Steven D. Valved prostheses with preformed tissue leaflets
US20040024447A1 (en) * 2000-04-27 2004-02-05 Axel Haverich Individual venous valve prosthesis
US20040030405A1 (en) * 1994-07-29 2004-02-12 Sophie Carpentier Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US20040030321A1 (en) * 2000-07-11 2004-02-12 Fangrow Thomas F. Medical valve with positive flow characteristics
US20040030381A1 (en) * 2002-07-16 2004-02-12 Shu Mark C.S. Heart valve prosthesis
US6692512B2 (en) * 1998-10-13 2004-02-17 Edwards Lifesciences Corporation Percutaneous filtration catheter for valve repair surgery and methods of use
US20040034380A1 (en) * 2001-06-29 2004-02-19 Woolfson Steven B. Method and apparatus for resecting and replacing an aortic valve
US20040034411A1 (en) * 2002-08-16 2004-02-19 Quijano Rodolfo C. Percutaneously delivered heart valve and delivery means thereof
US6695866B1 (en) * 1998-07-15 2004-02-24 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US6695878B2 (en) * 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US20040039436A1 (en) * 2001-10-11 2004-02-26 Benjamin Spenser Implantable prosthetic valve
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US6837902B2 (en) * 1997-04-03 2005-01-04 Edwards Lifesciences Corporation Methods of making bioprosthetic heart valves with strain matched leaflets
US20050004667A1 (en) * 2003-06-05 2005-01-06 Cardiac Dimensions, Inc. A Delaware Corporation Device, system and method to affect the mitral valve annulus of a heart
US6840246B2 (en) * 2000-06-20 2005-01-11 University Of Maryland, Baltimore Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart
US6842226B2 (en) * 2001-09-21 2005-01-11 Nikon Corporation Flexure supported wafer table
US20050010285A1 (en) * 1999-01-27 2005-01-13 Lambrecht Gregory H. Cardiac valve procedure methods and devices
US20050010287A1 (en) * 2000-09-20 2005-01-13 Ample Medical, Inc. Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet
US20050015112A1 (en) * 2000-01-27 2005-01-20 Cohn William E. Cardiac valve procedure methods and devices
US6846324B2 (en) * 1999-01-26 2005-01-25 Edwards Lifesciences Corporation Combination anatomical orifice sizer and heart valve
US6846325B2 (en) * 2000-09-07 2005-01-25 Viacor, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20050021136A1 (en) * 2002-03-21 2005-01-27 Hua Xie Method for suturelessly attaching a biomaterial to an implantable bioprosthesis frame
US20050027261A1 (en) * 2003-07-30 2005-02-03 Karla Weaver Pressure actuated valve with improved slit configuration
US20050027353A1 (en) * 2001-05-14 2005-02-03 Alferness Clifton A. Mitral valve therapy device, system and method
US20050027348A1 (en) * 2003-07-31 2005-02-03 Case Brian C. Prosthetic valve devices and methods of making such devices
US20050033398A1 (en) * 2001-07-31 2005-02-10 Jacques Seguin Assembly for setting a valve prosthesis in a corporeal duct
US20050038506A1 (en) * 2002-11-15 2005-02-17 Webler William E. Apparatuses and methods for heart valve repair
US6858039B2 (en) * 2002-07-08 2005-02-22 Edwards Lifesciences Corporation Mitral valve annuloplasty ring having a posterior bow
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20050043790A1 (en) * 2001-07-04 2005-02-24 Jacques Seguin Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body
US20060004442A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Paravalvular leak detection, sealing, and prevention
US20060000715A1 (en) * 2000-01-25 2006-01-05 Whitcher Forrest D Manufacturing medical devices by vapor deposition
US20060004439A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Device and method for assisting in the implantation of a prosthetic valve
US20060009842A1 (en) * 1997-03-27 2006-01-12 Huynh Van L Contoured heart valve suture rings
US20060009841A1 (en) * 2003-05-05 2006-01-12 Rex Medical Percutaneous aortic valve
US20060009804A1 (en) * 2004-07-12 2006-01-12 Pederson Brian D Anti-coagulation and demineralization system for conductive medical devices
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20060013805A1 (en) * 1998-11-24 2006-01-19 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
US20060015179A1 (en) * 2004-07-19 2006-01-19 Neil Bulman-Fleming Aortic annuloplasty ring
US20060015136A1 (en) * 2002-09-19 2006-01-19 Memory Metal Holland Bv Vascular filter with improved strength and flexibility
US20060013855A1 (en) * 2004-04-05 2006-01-19 Medivas, Llc Bioactive stents for type II diabetics and methods for use thereof
US6989027B2 (en) * 2003-04-30 2006-01-24 Medtronic Vascular Inc. Percutaneously delivered temporary valve assembly
US6989028B2 (en) * 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US20060020275A1 (en) * 1999-04-09 2006-01-26 Evalve, Inc. Locking mechanisms for fixation devices and methods of engaging tissue
US20060020327A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented heart valves with formed in situ support
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US20060020336A1 (en) * 2001-10-23 2006-01-26 Liddicoat John R Automated annular plication for mitral valve repair
US20060025784A1 (en) * 2003-09-04 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060025857A1 (en) * 2004-04-23 2006-02-02 Bjarne Bergheim Implantable prosthetic valve
US20060025750A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060025856A1 (en) * 2001-03-15 2006-02-02 Medtronic, Inc. Annuloplasty band and method
US20060030866A1 (en) * 2002-03-26 2006-02-09 Stefan Schreck Sequential heart valve leaflet repair device and method of use
US20060030747A1 (en) * 2004-07-09 2006-02-09 Kantrowitz Allen B Synchronization system between aortic valve and cardiac assist device
US20060030885A1 (en) * 2002-10-15 2006-02-09 Hyde Gregory M Apparatuses and methods for heart valve repair
US20060030882A1 (en) * 2002-03-06 2006-02-09 Adams John M Transvenous staples, assembly and method for mitral valve repair
US6997950B2 (en) * 2003-01-16 2006-02-14 Chawla Surendra K Valve repair device
US20060036317A1 (en) * 2002-11-12 2006-02-16 Myocor, Inc. Decives and methods for heart valve treatment
US20060041306A1 (en) * 2002-01-09 2006-02-23 Myocor, Inc. Devices and methods for heart valve treatment
US20060041305A1 (en) * 1996-06-20 2006-02-23 Karl-Lutz Lauterjung Prosthetic repair of body passages

Family Cites Families (465)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US690848A (en) * 1900-12-13 1902-01-07 John C Fleming Toilet cream.
US3671979A (en) 1969-09-23 1972-06-27 Univ Utah Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve
DE2355959B2 (en) 1973-11-09 1976-07-29 Artificial pocket flap for replacement of the aortic or pulmonary valve in the heart
US4222126A (en) * 1978-12-14 1980-09-16 The United States Of America As Represented By The Secretary Of The Department Of Health, Education & Welfare Unitized three leaflet heart valve
US7018407B1 (en) 1981-10-29 2006-03-28 Medtronic Valve holder for tricuspid heart valve
US5275622A (en) 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
DE3426300C2 (en) 1984-07-17 1987-12-03 Doguhan Dr.Med. 2800 Bremen De Baykut
US4935030A (en) 1985-06-17 1990-06-19 Medtronic, Inc. Mechanical heart valve prosthesis
WO1988000459A1 (en) 1986-07-17 1988-01-28 Quotidian No. 100 Pty. Limited Prosthetic venous valve
US4872874A (en) 1987-05-29 1989-10-10 Taheri Syde A Method and apparatus for transarterial aortic graft insertion and implantation
JPH0468939B2 (en) 1987-09-24 1992-11-04 Terumo Corp
IT1218947B (en) 1988-01-12 1990-04-24 Sorin Biomedica Spa cardiac valve prosthesis
SE8800244D0 (en) 1988-01-27 1988-01-27 Medical Innovation Ab Device for avskerning of venous valves
US5609626A (en) 1989-05-31 1997-03-11 Baxter International Inc. Stent devices and support/restrictor assemblies for use in conjunction with prosthetic vascular grafts
EP0474748B1 (en) 1989-05-31 1995-01-25 Baxter International Inc. Biological valvular prosthesis
EP0429629A4 (en) 1989-06-19 1991-11-13 Hugh H. Trout, Iii Aortic graft and method for repairing aneurysm
US5290300A (en) 1989-07-31 1994-03-01 Baxter International Inc. Flexible suture guide and holder
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
GB9012716D0 (en) * 1990-06-07 1990-08-01 Frater Robert W M Mitral heart valve replacements
US5578071A (en) 1990-06-11 1996-11-26 Parodi; Juan C. Aortic graft
AR246020A1 (en) 1990-10-03 1994-03-30 Hector Daniel Barone Juan Carl A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms.
US5272909A (en) 1991-04-25 1993-12-28 Baxter International Inc. Method and device for testing venous valves
US5370685A (en) 1991-07-16 1994-12-06 Stanford Surgical Technologies, Inc. Endovascular aortic valve replacement
US5441552A (en) 1991-11-27 1995-08-15 Delillo; Joseph Method and apparatus for composting solid waste and sludge
US5163953A (en) 1992-02-10 1992-11-17 Vince Dennis J Toroidal artificial heart valve stent
US5258023A (en) 1992-02-12 1993-11-02 Reger Medical Development, Inc. Prosthetic heart valve
US5234448A (en) 1992-02-28 1993-08-10 Shadyside Hospital Method and apparatus for connecting and closing severed blood vessels
US5332402A (en) 1992-05-12 1994-07-26 Teitelbaum George P Percutaneously-inserted cardiac valve
US5982645A (en) 1992-08-25 1999-11-09 Square D Company Power conversion and distribution system
EP0604022A1 (en) 1992-12-22 1994-06-29 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method for its manufacture
US5972030A (en) 1993-02-22 1999-10-26 Heartport, Inc. Less-invasive devices and methods for treatment of cardiac valves
FR2718951B1 (en) 1994-04-26 1996-07-26 Perouse Implant Laboratoire Tubular stent.
US5554185A (en) 1994-07-18 1996-09-10 Block; Peter C. Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same
FR2728457B1 (en) 1994-12-21 1997-03-21 Franceschi Claude artificial valve for blood vessel
BE1009278A3 (en) 1995-04-12 1997-01-07 Corvita Europ Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as.
US6391053B1 (en) 1995-06-07 2002-05-21 St. Jude Medical, Inc. Prosthetic heart valve with increased valve lumen
US6402780B2 (en) 1996-02-23 2002-06-11 Cardiovascular Technologies, L.L.C. Means and method of replacing a heart valve in a minimally invasive manner
US6273912B1 (en) 1996-02-28 2001-08-14 Impra, Inc. Flanged graft for end-to-side anastomosis
US5928916A (en) 1996-04-25 1999-07-27 Medtronic, Inc. Ionic attachment of biomolecules with a guanidino moiety to medical device surfaces
US5741326A (en) 1996-07-15 1998-04-21 Cordis Corporation Low profile thermally set wrapped cover for a percutaneously deployed stent
US6495334B1 (en) 1996-07-19 2002-12-17 Regents Of The University Of Minnesota Recombinant Sef14 fimbrial protein from Salmonella
US6764509B2 (en) 1996-09-06 2004-07-20 Carbomedics Inc. Prosthetic heart valve with surface modification
US5895419A (en) 1996-09-30 1999-04-20 St. Jude Medical, Inc. Coated prosthetic cardiac device
US5879320A (en) 1996-12-23 1999-03-09 Cazenave; Craig Richard Implantable vascular device
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
US5735859A (en) 1997-02-14 1998-04-07 Cathco, Inc. Distally attachable and releasable sheath for a stent delivery system
US6692912B1 (en) * 1997-03-05 2004-02-17 Matrix Technologies Corporation Nucleic acid-containing polymerizable complex
DE69828798T2 (en) 1997-03-05 2006-01-05 Boston Scientific Ltd., St. Michael Konformanliegende multilayer stent device
WO1998046115A2 (en) 1997-04-11 1998-10-22 Transvascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
DE19731834A1 (en) 1997-07-24 1999-06-17 Ernst Peter Prof Dr M Strecker implanter
FR2768324B1 (en) 1997-09-12 1999-12-10 Jacques Seguin A surgical instrument for percutaneously, fixing one to the other two zones of soft tissue, usually spaced apart
US5910170A (en) 1997-12-17 1999-06-08 St. Jude Medical, Inc. Prosthetic heart valve stent utilizing mounting clips
US6921811B2 (en) 1998-09-22 2005-07-26 Biosurface Engineering Technologies, Inc. Bioactive coating composition and methods
US6530952B2 (en) 1997-12-29 2003-03-11 The Cleveland Clinic Foundation Bioprosthetic cardiovascular valve system
EP2138132B1 (en) 1997-12-29 2012-06-06 The Cleveland Clinic Foundation Remote manipulation system for remotely manipulating an associated medical device
US6074418A (en) 1998-04-20 2000-06-13 St. Jude Medical, Inc. Driver tool for heart valve prosthesis fasteners
US7452371B2 (en) 1999-06-02 2008-11-18 Cook Incorporated Implantable vascular device
US6250308B1 (en) 1998-06-16 2001-06-26 Cardiac Concepts, Inc. Mitral valve annuloplasty ring and method of implanting
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
US6355030B1 (en) 1998-09-25 2002-03-12 Cardiothoracic Systems, Inc. Instruments and methods employing thermal energy for the repair and replacement of cardiac valves
US6540780B1 (en) 1998-11-23 2003-04-01 Medtronic, Inc. Porous synthetic vascular grafts with oriented ingrowth channels
US6736845B2 (en) 1999-01-26 2004-05-18 Edwards Lifesciences Corporation Holder for flexible heart valve
US6364905B1 (en) 1999-01-27 2002-04-02 Sulzer Carbomedics Inc. Tri-composite, full root, stentless valve
DE19904975A1 (en) 1999-02-06 2000-09-14 Impella Cardiotech Ag A device for intravascular cardiac valve surgery
US6425916B1 (en) 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US6666886B1 (en) 1999-02-16 2003-12-23 Regents Of The University Of Minnesota Tissue equivalent approach to a tissue-engineered cardiovascular valve
US6110201A (en) 1999-02-18 2000-08-29 Venpro Bifurcated biological pulmonary valved conduit
US6139575A (en) 1999-04-02 2000-10-31 Medtronic, Inc. Hybrid mechanical heart valve prosthesis
US7563267B2 (en) 1999-04-09 2009-07-21 Evalve, Inc. Fixation device and methods for engaging tissue
US20040044350A1 (en) * 1999-04-09 2004-03-04 Evalve, Inc. Steerable access sheath and methods of use
US6666885B2 (en) 1999-04-16 2003-12-23 Carbomedics Inc. Heart valve leaflet
EP1171059B1 (en) 1999-04-23 2005-11-02 St. Jude Medical ATG, Inc. Artificial heart valve attachment apparatus
BR0010096A (en) 1999-04-28 2002-02-19 St Jude Medical heart valve prosthesis, kit, method for connecting a heart valve prosthesis in a patient, and fastener applier for deploying a cardiac valve prosthesis
EP1187581A1 (en) 1999-05-06 2002-03-20 VenPro Corporation Implant for restoring venous valvular function
US6309417B1 (en) 1999-05-12 2001-10-30 Paul A. Spence Heart valve and apparatus for replacement thereof
US6790229B1 (en) 1999-05-25 2004-09-14 Eric Berreklouw Fixing device, in particular for fixing to vascular wall tissue
US20050267560A1 (en) 2000-02-03 2005-12-01 Cook Incorporated Implantable bioabsorbable valve support frame
US7628803B2 (en) 2001-02-05 2009-12-08 Cook Incorporated Implantable vascular device
US6241763B1 (en) 1999-06-08 2001-06-05 William J. Drasler In situ venous valve device and method of formation
US7192442B2 (en) 1999-06-30 2007-03-20 Edwards Lifesciences Ag Method and device for treatment of mitral insufficiency
AU7884800A (en) 1999-08-27 2001-03-26 Kimberly-Clark Worldwide, Inc. Absorbent article having pleated extensible absorbent layer
US6315793B1 (en) 1999-09-08 2001-11-13 Medical Carbon Research Institute, Llc Prosthetic venous valves
DE19945587A1 (en) 1999-09-23 2001-05-10 Co Don Ag A method for inserting implants into human organs
US6371983B1 (en) * 1999-10-04 2002-04-16 Ernest Lane Bioprosthetic heart valve
US7201771B2 (en) 2001-12-27 2007-04-10 Arbor Surgical Technologies, Inc. Bioprosthetic heart valve
US6626930B1 (en) 1999-10-21 2003-09-30 Edwards Lifesciences Corporation Minimally invasive mitral valve repair method and apparatus
JP2001120582A (en) 1999-10-22 2001-05-08 Gunze Ltd Artificial cardiac valve and method of manufacturing the same
US6723123B1 (en) 1999-11-10 2004-04-20 Impsa International Incorporated Prosthetic heart valve
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
FR2800984B1 (en) 1999-11-17 2001-12-14 Jacques Seguin Device for replacing a heart valve percutaneously
US7195641B2 (en) * 1999-11-19 2007-03-27 Advanced Bio Prosthetic Surfaces, Ltd. Valvular prostheses having metal or pseudometallic construction and methods of manufacture
US6709457B1 (en) 1999-11-24 2004-03-23 St. Jude Medical, Inc. Attachment of suture cuff to prosthetic heart valve
SE9904569L (en) 1999-12-14 2001-05-14 Jcl Technic Ab Vascular valve, such as heart valves, and process for its preparation
EP1243284A4 (en) 1999-12-24 2006-03-29 Toray Industries Catheter with balloon
US6458153B1 (en) * 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
CN1806775A (en) 2000-01-14 2006-07-26 维亚科公司 Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the same
AT431165T (en) 2000-01-25 2009-05-15 Edwards Lifesciences Corp Bioactive coatings for prevention of tissue growth on artificial heart valves
US6872226B2 (en) 2001-01-29 2005-03-29 3F Therapeutics, Inc. Method of cutting material for use in implantable medical device
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
US7011682B2 (en) 2000-01-31 2006-03-14 Edwards Lifesciences Ag Methods and apparatus for remodeling an extravascular tissue structure
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US7510576B2 (en) 2001-01-30 2009-03-31 Edwards Lifesciences Ag Transluminal mitral annuloplasty
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US20050070999A1 (en) 2000-02-02 2005-03-31 Spence Paul A. Heart valve repair apparatus and methods
US6821297B2 (en) 2000-02-02 2004-11-23 Robert V. Snyders Artificial heart valve, implantation instrument and method therefor
ES2236204T3 (en) * 2000-03-03 2005-07-16 Cook Incorporated And bulbous valve stent for the treatment of vascular reflux.
US20030229393A1 (en) 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
US6454799B1 (en) 2000-04-06 2002-09-24 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
US6652583B2 (en) 2000-04-07 2003-11-25 Rhode Island Hospital Cardiac valve replacement
US6869444B2 (en) 2000-05-22 2005-03-22 Shlomo Gabbay Low invasive implantable cardiac prosthesis and method for helping improve operation of a heart valve
US8366769B2 (en) 2000-06-01 2013-02-05 Edwards Lifesciences Corporation Low-profile, pivotable heart valve sewing ring
US6805711B2 (en) 2000-06-02 2004-10-19 3F Therapeutics, Inc. Expandable medical implant and percutaneous delivery
US20050043757A1 (en) 2000-06-12 2005-02-24 Michael Arad Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof
WO2001097897A1 (en) 2000-06-20 2001-12-27 Starion Instruments, Inc. Devices and methods for repair of valves in the human body
US6702826B2 (en) 2000-06-23 2004-03-09 Viacor, Inc. Automated annular plication for mitral valve repair
US6913608B2 (en) 2000-10-23 2005-07-05 Viacor, Inc. Automated annular plication for mitral valve repair
SE0002514D0 (en) 2000-06-30 2000-06-30 Pacesetter Ab Medical device
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US6769434B2 (en) 2000-06-30 2004-08-03 Viacor, Inc. Method and apparatus for performing a procedure on a cardiac valve
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US7077861B2 (en) 2000-07-06 2006-07-18 Medtentia Ab Annuloplasty instrument
SE0002878D0 (en) 2000-08-11 2000-08-11 Kimblad Ola Device and method for the treatment of atrioventricular regurgitation
US6635085B1 (en) 2000-08-17 2003-10-21 Carbomedics Inc. Heart valve stent with alignment posts
US6572652B2 (en) 2000-08-29 2003-06-03 Venpro Corporation Method and devices for decreasing elevated pulmonary venous pressure
WO2002022054A1 (en) 2000-09-12 2002-03-21 Gabbay S Valvular prosthesis and method of using same
US20060142848A1 (en) 2000-09-12 2006-06-29 Shlomo Gabbay Extra-anatomic aortic valve placement
DE10046550A1 (en) 2000-09-19 2002-03-28 Adiam Life Science Ag Prosthetic mitral heart valve consists of support housing with base ring and two stanchions
US20060106278A1 (en) 2004-05-14 2006-05-18 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of an adjustable bridge implant system
US8784482B2 (en) 2000-09-20 2014-07-22 Mvrx, Inc. Method of reshaping a heart valve annulus using an intravascular device
US7527646B2 (en) 2000-09-20 2009-05-05 Ample Medical, Inc. Devices, systems, and methods for retaining a native heart valve leaflet
US6893459B1 (en) 2000-09-20 2005-05-17 Ample Medical, Inc. Heart valve annulus device and method of using same
US20050228422A1 (en) 2002-11-26 2005-10-13 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
US8956407B2 (en) 2000-09-20 2015-02-17 Mvrx, Inc. Methods for reshaping a heart valve annulus using a tensioning implant
US20060106279A1 (en) 2004-05-14 2006-05-18 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant having an adjustable bridge stop
US6461382B1 (en) 2000-09-22 2002-10-08 Edwards Lifesciences Corporation Flexible heart valve having moveable commissures
AU9644201A (en) 2000-09-29 2002-04-08 Tricardia Llc Venous valvuloplasty device and method
US6602288B1 (en) 2000-10-05 2003-08-05 Edwards Lifesciences Corporation Minimally-invasive annuloplasty repair segment delivery template, system and method of use
US6723038B1 (en) 2000-10-06 2004-04-20 Myocor, Inc. Methods and devices for improving mitral valve function
DE10049865B8 (en) 2000-10-09 2008-10-30 Albert-Ludwigs-Universität Apparatus for removing an aortic valve on the human heart through a minimally invasive surgical procedure
US6918917B1 (en) 2000-10-10 2005-07-19 Medtronic, Inc. Minimally invasive annuloplasty procedure and apparatus
US6926730B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Minimally invasive valve repair procedure and apparatus
US7070618B2 (en) 2000-10-25 2006-07-04 Viacor, Inc. Mitral shield
US6602286B1 (en) 2000-10-26 2003-08-05 Ernst Peter Strecker Implantable valve system
US20040044403A1 (en) * 2001-10-30 2004-03-04 Joyce Bischoff Tissue-engineered vascular structures
US6953332B1 (en) 2000-11-28 2005-10-11 St. Jude Medical, Inc. Mandrel for use in forming valved prostheses having polymer leaflets by dip coating
US6730122B1 (en) 2000-11-28 2004-05-04 St. Jude Medical, Inc. Prosthetic heart valve with increased lumen
WO2002047539A2 (en) 2000-12-15 2002-06-20 Viacor, Inc. Apparatus and method for replacing aortic valve
US6716244B2 (en) 2000-12-20 2004-04-06 Carbomedics, Inc. Sewing cuff assembly for heart valves
US6964682B2 (en) 2000-12-21 2005-11-15 Edwards Lifesciences Corporation Heart valve holder that resist suture looping
US6966925B2 (en) 2000-12-21 2005-11-22 Edwards Lifesciences Corporation Heart valve holder and method for resisting suture looping
US6669725B2 (en) 2000-12-28 2003-12-30 Centerpulse Biologics Inc. Annuloplasty ring for regeneration of diseased or damaged heart valve annulus
AU2002243851A1 (en) 2001-02-05 2002-08-19 Viacor, Inc. Apparatus and method for reducing mitral regurgitation
US6656221B2 (en) 2001-02-05 2003-12-02 Viacor, Inc. Method and apparatus for improving mitral valve function
WO2002076284A2 (en) 2001-03-23 2002-10-03 Viacor, Inc. Method and apparatus for reducing mitral regurgitation
US7125420B2 (en) 2002-02-05 2006-10-24 Viacor, Inc. Method and apparatus for improving mitral valve function
US7186264B2 (en) 2001-03-29 2007-03-06 Viacor, Inc. Method and apparatus for improving mitral valve function
US20020107531A1 (en) 2001-02-06 2002-08-08 Schreck Stefan G. Method and system for tissue repair using dual catheters
US6786924B2 (en) 2001-03-15 2004-09-07 Medtronic, Inc. Annuloplasty band and method
WO2002074201A1 (en) 2001-03-16 2002-09-26 Mayo Foundation For Medical Education And Research Synthethic leaflets for heart valve repair or replacement
AUPR389201A0 (en) 2001-03-23 2001-04-12 Lane, Rodney James Improvements in design of external vendus valve stents for the correction fo incompetent vendods valves
US6958076B2 (en) 2001-04-16 2005-10-25 Biomedical Research Associates Inc. Implantable venous valve
US7037334B1 (en) 2001-04-24 2006-05-02 Mitralign, Inc. Method and apparatus for catheter-based annuloplasty using local plications
US20050125011A1 (en) 2001-04-24 2005-06-09 Spence Paul A. Tissue fastening systems and methods utilizing magnetic guidance
US20060069429A1 (en) 2001-04-24 2006-03-30 Spence Paul A Tissue fastening systems and methods utilizing magnetic guidance
DE10121210B4 (en) 2001-04-30 2005-11-17 Universitätsklinikum Freiburg Anchoring element for intraluminal anchoring a replacement heart valve and method for its preparation
US20040193253A1 (en) 2001-04-30 2004-09-30 Thorpe Patricia E Replacement venous valve
US6936067B2 (en) 2001-05-17 2005-08-30 St. Jude Medical Inc. Prosthetic heart valve with slit stent
ITMI20011012A1 (en) 2001-05-17 2002-11-18 Ottavio Alfieri annular prosthesis for mitral valve
US20020173811A1 (en) 2001-05-21 2002-11-21 Hosheng Tu Apparatus and methods for valve removal
US7377938B2 (en) 2001-07-19 2008-05-27 The Cleveland Clinic Foundation Prosthetic cardiac value and method for making same
AU2005260008B2 (en) 2004-06-29 2009-07-16 The Cleveland Clinic Foundation Prosthetic cardiac valve and method for making same
US6726716B2 (en) 2001-08-24 2004-04-27 Edwards Lifesciences Corporation Self-molding annuloplasty ring
US6749630B2 (en) 2001-08-28 2004-06-15 Edwards Lifesciences Corporation Tricuspid ring and template
US6723122B2 (en) 2001-08-30 2004-04-20 Edwards Lifesciences Corporation Container and method for storing and delivering minimally-invasive heart valves
US7101395B2 (en) 2002-06-12 2006-09-05 Mitral Interventions, Inc. Method and apparatus for tissue connection
US7556646B2 (en) * 2001-09-13 2009-07-07 Edwards Lifesciences Corporation Methods and apparatuses for deploying minimally-invasive heart valves
CN100333704C (en) 2001-10-01 2007-08-29 安普尔医药公司 Methods and devices for heart valve treatments
AU2003277116A1 (en) 2002-10-01 2004-04-23 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus
US7144363B2 (en) 2001-10-16 2006-12-05 Extensia Medical, Inc. Systems for heart treatment
US6726715B2 (en) 2001-10-23 2004-04-27 Childrens Medical Center Corporation Fiber-reinforced heart valve prosthesis
US6949122B2 (en) 2001-11-01 2005-09-27 Cardiac Dimensions, Inc. Focused compression mitral valve device and method
US6805710B2 (en) 2001-11-13 2004-10-19 Edwards Lifesciences Corporation Mitral valve annuloplasty ring for molding left ventricle geometry
US6575971B2 (en) 2001-11-15 2003-06-10 Quantum Cor, Inc. Cardiac valve leaflet stapler device and methods thereof
US6719784B2 (en) 2001-11-21 2004-04-13 Scimed Life Systems, Inc. Counter rotational layering of ePTFE to improve mechanical properties of a prosthesis
US20050228479A1 (en) 2001-11-29 2005-10-13 Cook Incorporated Medical device delivery system
US6908478B2 (en) 2001-12-05 2005-06-21 Cardiac Dimensions, Inc. Anchor and pull mitral valve device and method
US6978176B2 (en) 2001-12-08 2005-12-20 Lattouf Omar M Treatment for patient with congestive heart failure
US6755857B2 (en) 2001-12-12 2004-06-29 Sulzer Carbomedics Inc. Polymer heart valve with perforated stent and sewing cuff
JP4230915B2 (en) 2001-12-21 2009-02-25 シムチャ ミロ Transplant system for the annuloplasty ring
US6951573B1 (en) 2001-12-22 2005-10-04 Dilling Emery W Prosthetic aortic valve
US20030120340A1 (en) 2001-12-26 2003-06-26 Jan Liska Mitral and tricuspid valve repair
US6881224B2 (en) 2001-12-28 2005-04-19 St. Jude Medical, Inc. Fatigue test for prosthetic stent
EP2181668A1 (en) 2001-12-28 2010-05-05 Edwards Lifesciences AG Device for treating mitral annulus dilatation comprising a balloon catheter and a stent
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US20030130729A1 (en) 2002-01-04 2003-07-10 David Paniagua Percutaneously implantable replacement heart valve device and method of making same
US7311729B2 (en) 2002-01-30 2007-12-25 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US6976995B2 (en) 2002-01-30 2005-12-20 Cardiac Dimensions, Inc. Fixed length anchor and pull mitral valve device and method
AU2004243029B2 (en) 2003-05-27 2009-12-03 Viacor, Inc. Method and apparatus for improving mitral valve function
EP1476095A4 (en) 2002-02-20 2007-04-25 Francisco J Osse Venous bi-valve
DE10208202A1 (en) 2002-02-26 2003-09-11 Karlsruhe Forschzent vein graft
US6974464B2 (en) 2002-02-28 2005-12-13 3F Therapeutics, Inc. Supportless atrioventricular heart valve and minimally invasive delivery systems thereof
US7048754B2 (en) 2002-03-01 2006-05-23 Evalve, Inc. Suture fasteners and methods of use
US6716241B2 (en) 2002-03-05 2004-04-06 John G. Wilder Venous valve and graft combination
US6797001B2 (en) 2002-03-11 2004-09-28 Cardiac Dimensions, Inc. Device, assembly and method for mitral valve repair
US6719786B2 (en) 2002-03-18 2004-04-13 Medtronic, Inc. Flexible annuloplasty prosthesis and holder
US6752828B2 (en) 2002-04-03 2004-06-22 Scimed Life Systems, Inc. Artificial valve
US7160320B2 (en) 2002-04-16 2007-01-09 The International Heart Institute Of Montana Foundation Reed valve for implantation into mammalian blood vessels and heart with optional temporary or permanent support
US7125418B2 (en) 2002-04-16 2006-10-24 The International Heart Institute Of Montana Foundation Sigmoid valve and method for its percutaneous implantation
DE10217559B4 (en) 2002-04-19 2004-02-19 Universitätsklinikum Freiburg A device for minimally invasive, intravascular Aortenklappenextraktion
FR2838631B1 (en) 2002-04-23 2004-12-24 Engeneering And Technological A method of making a prosthesis for aortic or mitral heart valve prosthesis and aortic or mitral heart valve thus obtained
US6761735B2 (en) 2002-04-25 2004-07-13 Medtronic, Inc. Heart valve fixation process and apparatus
US6676699B2 (en) * 2002-04-26 2004-01-13 Medtronic Ave, Inc Stent graft with integrated valve device and method
AU2003234505A1 (en) 2002-05-03 2003-11-17 The General Hospital Corporation Involuted endovascular valve and method of construction
AT417573T (en) 2002-05-08 2009-01-15 Cardiac Dimensions Inc Means for changing the shape of a mitral valve
US6824562B2 (en) 2002-05-08 2004-11-30 Cardiac Dimensions, Inc. Body lumen device anchor, device and assembly
US7351256B2 (en) 2002-05-10 2008-04-01 Cordis Corporation Frame based unidirectional flow prosthetic implant
US20030229394A1 (en) 2002-06-06 2003-12-11 Ogle Matthew F. Processed tissue for medical device formation
US8287555B2 (en) 2003-02-06 2012-10-16 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US7758637B2 (en) 2003-02-06 2010-07-20 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7666193B2 (en) 2002-06-13 2010-02-23 Guided Delivery Sytems, Inc. Delivery devices and methods for heart valve repair
US20040243227A1 (en) 2002-06-13 2004-12-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20050216078A1 (en) 2002-06-13 2005-09-29 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US7959674B2 (en) 2002-07-16 2011-06-14 Medtronic, Inc. Suture locking assembly and method of use
US6761734B2 (en) 2002-07-22 2004-07-13 William S. Suhr Segmented balloon catheter for stenting bifurcation lesions
US8172856B2 (en) 2002-08-02 2012-05-08 Cedars-Sinai Medical Center Methods and apparatus for atrioventricular valve repair
DE20321838U1 (en) 2002-08-13 2011-02-10 JenaValve Technology Inc., Wilmington Device for anchoring and orientation of prosthetic heart valves
EP1534146B1 (en) 2002-08-13 2008-01-23 The General Hospital Corporation Cardiac devices for percutaneous repair of atrioventricular valves
US6889103B2 (en) 2002-08-22 2005-05-03 Atser Systems and methods for realtime determination of asphalt content
EP1592367B1 (en) 2002-08-28 2016-04-13 HLT, Inc. Method and device for treating diseased valve
US7083628B2 (en) 2002-09-03 2006-08-01 Edwards Lifesciences Corporation Single catheter mitral valve repair device and method for use
US6875231B2 (en) 2002-09-11 2005-04-05 3F Therapeutics, Inc. Percutaneously deliverable heart valve
CO5500017A1 (en) 2002-09-23 2005-03-31 3F Therapeutics Inc prosthetic mitral valve
US20040059412A1 (en) 2002-09-25 2004-03-25 Lytle Thomas William Heart valve holder
US20040060161A1 (en) 2002-09-27 2004-04-01 David Leal Methods of forming a heart valve stent
EP1549257A4 (en) 2002-10-10 2006-09-06 Cleveland Clinic Foundation Method and apparatus for replacing a mitral valve with a stentless bioprosthetic valve
US8979923B2 (en) 2002-10-21 2015-03-17 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US8460371B2 (en) 2002-10-21 2013-06-11 Mitralign, Inc. Method and apparatus for performing catheter-based annuloplasty using local plications
US7416557B2 (en) 2002-10-24 2008-08-26 Boston Scientific Scimed, Inc. Venous valve apparatus and method
GB0225075D0 (en) 2002-10-29 2002-12-04 Smiths Group Plc Valves
US20040082910A1 (en) 2002-10-29 2004-04-29 Constantz Brent R. Devices and methods for treating aortic valve stenosis
US7247134B2 (en) 2002-11-12 2007-07-24 Myocor, Inc. Devices and methods for heart valve treatment
DE60314273T2 (en) 2002-11-12 2008-02-07 Myocor, Inc. Devices for herzklappenbehandelung
US7255706B2 (en) 2002-11-13 2007-08-14 Rosengart Todd K Apparatus and method for cutting a heart valve
EP2345380B1 (en) 2002-11-13 2018-01-10 Medtronic, Inc. Cardiac valve procedure devices
US20040097979A1 (en) 2002-11-14 2004-05-20 Oleg Svanidze Aortic valve implantation device
US6945978B1 (en) 2002-11-15 2005-09-20 Advanced Cardiovascular Systems, Inc. Heart valve catheter
FR2847151B1 (en) 2002-11-15 2005-01-21 Claude Mialhe Occlusive device for medical or surgical destination
AU2003290979A1 (en) 2002-11-15 2004-06-15 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Method and device for catheter-based repair of cardiac valves
US20040122515A1 (en) 2002-11-21 2004-06-24 Xi Chu Prosthetic valves and methods of manufacturing
US7316708B2 (en) 2002-12-05 2008-01-08 Cardiac Dimensions, Inc. Medical device delivery system
WO2006034245A2 (en) 2004-09-20 2006-03-30 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty delivery system
US8551162B2 (en) 2002-12-20 2013-10-08 Medtronic, Inc. Biologically implantable prosthesis
US6945957B2 (en) 2002-12-30 2005-09-20 Scimed Life Systems, Inc. Valve treatment catheter and methods
US20040133240A1 (en) 2003-01-07 2004-07-08 Cardiac Dimensions, Inc. Electrotherapy system, device, and method for treatment of cardiac valve dysfunction
US6830585B1 (en) 2003-01-14 2004-12-14 3F Therapeutics, Inc. Percutaneously deliverable heart valve and methods of implantation
US6889148B2 (en) 2003-01-21 2005-05-03 Atser Process control system to manage materials used in construction
US6746463B1 (en) 2003-01-27 2004-06-08 Scimed Life Systems, Inc Device for percutaneous cutting and dilating a stenosis of the aortic valve
US7220271B2 (en) 2003-01-30 2007-05-22 Ev3 Inc. Embolic filters having multiple layers and controlled pore size
WO2004066803A2 (en) 2003-01-31 2004-08-12 Koninklijke Philips Electronics N.V. Magnetic resonance compatible stent
US7314485B2 (en) 2003-02-03 2008-01-01 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040158321A1 (en) 2003-02-12 2004-08-12 Cardiac Dimensions, Inc. Method of implanting a mitral valve therapy device
US8157810B2 (en) * 2003-02-26 2012-04-17 Cook Medical Technologies Llc Prosthesis adapted for placement under external imaging
US20040254600A1 (en) 2003-02-26 2004-12-16 David Zarbatany Methods and devices for endovascular mitral valve correction from the left coronary sinus
EP2168536B1 (en) 2003-03-12 2016-04-27 Cook Medical Technologies LLC Prosthetic valve that permits retrograde flow
US7381210B2 (en) 2003-03-14 2008-06-03 Edwards Lifesciences Corporation Mitral valve repair system and method for use
WO2004082528A2 (en) 2003-03-17 2004-09-30 Cook Incorporated Vascular valve with removable support component
WO2004082538A2 (en) 2003-03-18 2004-09-30 St. Jude Medical, Inc. Body tissue remodeling apparatus
US7399315B2 (en) 2003-03-18 2008-07-15 Edwards Lifescience Corporation Minimally-invasive heart valve with cusp positioners
US7988679B2 (en) 2003-03-18 2011-08-02 Navilyst Medical, Inc. Pressure responsive slit valve assembly for a plurality of fluids and uses thereof
WO2004082530A2 (en) 2003-03-19 2004-09-30 Cook Incorporated Delivery systems for deploying expandable intraluminal medical devices
JP4473861B2 (en) 2003-03-20 2010-06-02 エイオアテック、インターナショナル、ピーエルシー valve
CH696185A5 (en) 2003-03-21 2007-02-15 Afksendiyos Kalangos Intraparietal reinforcement for aortic valve and reinforced valve has rod inserted in biological tissue or organic prosthesis with strut fixed to one end
SE0300854D0 (en) 2003-03-26 2003-03-26 Oeyvind Reitan Ancestors Ding for the treatment of a hjärtklaffs insufficiency
KR100466839B1 (en) 2003-03-28 2005-01-17 주식회사 사이언씨티 Aortic valve Repairing Apparatus Sets and Treatment Method Using The Same
US20060271081A1 (en) 2003-03-30 2006-11-30 Fidel Realyvasquez Apparatus and methods for valve repair
US20050075659A1 (en) 2003-03-30 2005-04-07 Fidel Realyvasquez Apparatus and methods for minimally invasive valve surgery
EP1610728B1 (en) 2003-04-01 2011-05-25 Cook Incorporated Percutaneously deployed vascular valves
US7670366B2 (en) 2003-04-08 2010-03-02 Cook Incorporated Intraluminal support device with graft
US7159593B2 (en) 2003-04-17 2007-01-09 3F Therapeutics, Inc. Methods for reduction of pressure effects of cardiac tricuspid valve regurgitation
US7530995B2 (en) 2003-04-17 2009-05-12 3F Therapeutics, Inc. Device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US8083707B2 (en) 2003-04-17 2011-12-27 Tosaya Carol A Non-contact damage-free ultrasonic cleaning of implanted or natural structures having moving parts and located in a living body
US6945996B2 (en) 2003-04-18 2005-09-20 Sedransk Kyra L Replacement mitral valve
US7175656B2 (en) 2003-04-18 2007-02-13 Alexander Khairkhahan Percutaneous transcatheter heart valve replacement
US20040210240A1 (en) 2003-04-21 2004-10-21 Sean Saint Method and repair device for treating mitral valve insufficiency
US20050240255A1 (en) 2004-04-23 2005-10-27 Schaeffer Darin G Carrier-Based Delivery System for Intraluminal Medical Devices
WO2004093745A1 (en) 2003-04-23 2004-11-04 Cook Incorporated Devices kits, and methods for placing multiple intraluminal medical devices in a body vessel
JP4940388B2 (en) * 2003-04-24 2012-05-30 クック メディカル テクノロジーズ エルエルシーCook Medical Technologies Llc Prosthetic valve proteinase with improved hydrodynamic characteristics - Ze
US20040267357A1 (en) 2003-04-30 2004-12-30 Allen Jeffrey W. Cardiac valve modification method and device
US20040220657A1 (en) 2003-05-02 2004-11-04 Cardiac Dimensions, Inc., A Washington Corporation Tissue shaping device with conformable anchors
US20040220654A1 (en) 2003-05-02 2004-11-04 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040225356A1 (en) 2003-05-09 2004-11-11 Frater Robert W. Flexible heart valve
US7128759B2 (en) 2003-05-19 2006-10-31 Cook Incorporated Implantable medical device with constrained expansion
US8512403B2 (en) 2003-05-20 2013-08-20 The Cleveland Clinic Foundation Annuloplasty ring with wing members for repair of a cardiac valve
DE602004029159D1 (en) 2003-05-28 2010-10-28 Cook Inc
US7007396B2 (en) 2003-05-29 2006-03-07 Plc Medical Systems, Inc. Replacement heart valve sizing device
TW590007U (en) 2003-06-06 2004-06-01 Univ Tamkang Tri-leaflet mechanical heart valve
WO2005004753A1 (en) 2003-06-09 2005-01-20 3F Therapeutics, Inc. Atrioventricular heart valve and minimally invasive delivery systems thereof
US20070093869A1 (en) 2003-06-20 2007-04-26 Medtronic Vascular, Inc. Device, system, and method for contracting tissue in a mammalian body
US20060282161A1 (en) 2003-06-20 2006-12-14 Medtronic Vascular, Inc. Valve annulus reduction system
US20040260394A1 (en) 2003-06-20 2004-12-23 Medtronic Vascular, Inc. Cardiac valve annulus compressor system
US7316706B2 (en) 2003-06-20 2008-01-08 Medtronic Vascular, Inc. Tensioning device, system, and method for treating mitral valve regurgitation
US7537592B2 (en) 2003-06-20 2009-05-26 Plc Medical Systems, Inc. Endovascular tissue removal device
EP1635724A2 (en) 2003-06-20 2006-03-22 PLC Medical Systems, Inc. Endovascular tissue removal device
US20040267349A1 (en) 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
US8052751B2 (en) 2003-07-02 2011-11-08 Flexcor, Inc. Annuloplasty rings for repairing cardiac valves
US7201772B2 (en) 2003-07-08 2007-04-10 Ventor Technologies, Ltd. Fluid flow prosthetic device
WO2005002466A2 (en) 2003-07-08 2005-01-13 Ventor Technologies Ltd. Implantable prosthetic devices particularly for transarterial delivery in the treatment of aortic stenosis, and methods of implanting such devices
WO2005007037A1 (en) 2003-07-11 2005-01-27 Vedic Biotechnology, Inc. Selective annuloplasty for atrio-ventricular heart valve regurgitation and devices therefor
AU2003304421B2 (en) 2003-07-14 2009-12-03 Qiagen Sciences, Inc. Sample presentation device with differing wettability
NZ527025A (en) 2003-07-16 2007-01-26 David Peter Shaw Prosthetic valves for medical application
WO2005007018A2 (en) 2003-07-16 2005-01-27 The Regents Of The University Of California Thin-film metal alloy biomedical implantable devices
JP4599353B2 (en) 2003-07-17 2010-12-15 コラゾン テクノロジーズ インコーポレーティッド Percutaneously treat apparatus aortic valve stenosis
WO2005007036A1 (en) 2003-07-18 2005-01-27 Brivant Research & Development Limited A device for correcting inversion of the leaflets of a leaflet valve in the heart
US7744620B2 (en) 2003-07-18 2010-06-29 Intervalve, Inc. Valvuloplasty catheter
CA2533020A1 (en) 2003-07-18 2005-03-03 Ev3 Santa Rosa, Inc. Remotely activated mitral annuloplasty system and methods
EP1653888B1 (en) 2003-07-21 2009-09-09 The Trustees of The University of Pennsylvania Percutaneous heart valve
AU2004259206B2 (en) 2003-07-22 2009-12-17 Corazon Technologies, Inc. Devices and methods for treating aortic valve stenosis
AU2004258950B2 (en) 2003-07-23 2010-11-04 Viacor, Inc. Method and apparatus for improving mitral valve function
US7204255B2 (en) 2003-07-28 2007-04-17 Plc Medical Systems, Inc. Endovascular tissue removal device
DE10334868B4 (en) 2003-07-29 2013-10-17 Pfm Medical Ag The implantable device as an organ valve replacement, its manufacturing method and the substrate and diaphragm element therefor
WO2005011535A2 (en) 2003-07-31 2005-02-10 Cook Incorporated Prosthetic valve for implantation in a body vessel
FR2858543B1 (en) 2003-08-08 2006-02-03 Assist Publ Hopitaux De Paris and ancillary aortic ring for his pose
DE10340265A1 (en) 2003-08-29 2005-04-07 Sievers, Hans-Hinrich, Prof. Dr.med. Prosthesis for replacement of the aortic and / or mitral valve of the heart
US20050049692A1 (en) 2003-09-02 2005-03-03 Numamoto Michael J. Medical device for reduction of pressure effects of cardiac tricuspid valve regurgitation
US7753922B2 (en) 2003-09-04 2010-07-13 Guided Delivery Systems, Inc. Devices and methods for cardiac annulus stabilization and treatment
WO2005027797A1 (en) 2003-09-23 2005-03-31 Ersin Erek A mitral web apparatus for mitral valve insufficiencies
EG24012A (en) 2003-09-24 2008-03-23 Wael Mohamed Nabil Lotfy Valved balloon stent
US20050075725A1 (en) 2003-10-02 2005-04-07 Rowe Stanton J. Implantable prosthetic valve with non-laminar flow
US20050075720A1 (en) 2003-10-06 2005-04-07 Nguyen Tuoc Tan Minimally invasive valve replacement system
EP1684671A4 (en) 2003-10-06 2010-12-01 3F Therapeutics Inc Minimally invasive valve replacement system
EP1684656B1 (en) 2003-10-17 2016-12-07 Edwards Lifesciences AG Heart valve leaflet locator
US7004176B2 (en) * 2003-10-17 2006-02-28 Edwards Lifesciences Ag Heart valve leaflet locator
US7258698B2 (en) 2003-10-17 2007-08-21 Medtronic, Inc. Prosthetic heart valve sizer assembly with flexible sizer body
ITBO20030631A1 (en) 2003-10-23 2005-04-24 Roberto Erminio Parravicini valvular prosthetic apparatus, in particular for cardiac applications.
DE10350287A1 (en) 2003-10-24 2005-05-25 Deutsche Institute für Textil- und Faserforschung Stuttgart - Stiftung des öffentlichen Rechts Cardiovascular implant, for use as a vascular or heart valve replacement, comprises a non-resorbable polymer formed as a microfiber fleece that allows colonization by a cells
US7347869B2 (en) 2003-10-31 2008-03-25 Cordis Corporation Implantable valvular prosthesis
US7070616B2 (en) 2003-10-31 2006-07-04 Cordis Corporation Implantable valvular prosthesis
US7416530B2 (en) 2003-11-04 2008-08-26 L & P 100 Limited Medical devices
WO2006048664A2 (en) 2004-11-04 2006-05-11 L & P 100 Limited Medical devices
US7473274B2 (en) 2003-11-12 2009-01-06 Medtronic Vascular, Inc. Coronary sinus approach for repair of mitral valve regurgitation
WO2005046488A2 (en) 2003-11-12 2005-05-26 Medtronic Vascular, Inc. Cardiac valve annulus reduction system
WO2005048883A1 (en) 2003-11-13 2005-06-02 Fidel Realyvasquez Methods and apparatus for valve repair
US7740656B2 (en) 2003-11-17 2010-06-22 Medtronic, Inc. Implantable heart valve prosthetic devices having intrinsically conductive polymers
WO2005055811A2 (en) 2003-12-02 2005-06-23 Fidel Realyvasquez Methods and apparatus for mitral valve repair
WO2005055883A1 (en) 2003-12-04 2005-06-23 The Brigham And Women's Hospital, Inc. Aortic valve annuloplasty rings
US7186265B2 (en) 2003-12-10 2007-03-06 Medtronic, Inc. Prosthetic cardiac valves and systems and methods for implanting thereof
CA2548541A1 (en) 2003-12-16 2005-06-30 Edwards Lifesciences Ag Device for changing the shape of the mitral annulus
US20050177228A1 (en) 2003-12-16 2005-08-11 Solem Jan O. Device for changing the shape of the mitral annulus
US7837728B2 (en) 2003-12-19 2010-11-23 Cardiac Dimensions, Inc. Reduced length tissue shaping device
US7794496B2 (en) 2003-12-19 2010-09-14 Cardiac Dimensions, Inc. Tissue shaping device with integral connector and crimp
US8128681B2 (en) 2003-12-19 2012-03-06 Boston Scientific Scimed, Inc. Venous valve apparatus, system, and method
US20050137449A1 (en) 2003-12-19 2005-06-23 Cardiac Dimensions, Inc. Tissue shaping device with self-expanding anchors
US20050137450A1 (en) 2003-12-19 2005-06-23 Cardiac Dimensions, Inc., A Washington Corporation Tapered connector for tissue shaping device
US7854761B2 (en) 2003-12-19 2010-12-21 Boston Scientific Scimed, Inc. Methods for venous valve replacement with a catheter
US7261732B2 (en) 2003-12-22 2007-08-28 Henri Justino Stent mounted valve
US7445631B2 (en) 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US7329279B2 (en) 2003-12-23 2008-02-12 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050137686A1 (en) 2003-12-23 2005-06-23 Sadra Medical, A Delaware Corporation Externally expandable heart valve anchor and method
US7824442B2 (en) 2003-12-23 2010-11-02 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US9526609B2 (en) 2003-12-23 2016-12-27 Boston Scientific Scimed, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
US8182528B2 (en) 2003-12-23 2012-05-22 Sadra Medical, Inc. Locking heart valve anchor
US7166127B2 (en) 2003-12-23 2007-01-23 Mitralign, Inc. Tissue fastening systems and methods utilizing magnetic guidance
US20050137696A1 (en) 2003-12-23 2005-06-23 Sadra Medical Apparatus and methods for protecting against embolization during endovascular heart valve replacement
US8840663B2 (en) 2003-12-23 2014-09-23 Sadra Medical, Inc. Repositionable heart valve method
US8603160B2 (en) 2003-12-23 2013-12-10 Sadra Medical, Inc. Method of using a retrievable heart valve anchor with a sheath
US8343213B2 (en) 2003-12-23 2013-01-01 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US7748389B2 (en) 2003-12-23 2010-07-06 Sadra Medical, Inc. Leaflet engagement elements and methods for use thereof
US8246675B2 (en) 2003-12-23 2012-08-21 Laboratoires Perouse Kit for implanting in a duct
US7381219B2 (en) 2003-12-23 2008-06-03 Sadra Medical, Inc. Low profile heart valve and delivery system
US7959666B2 (en) 2003-12-23 2011-06-14 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a heart valve
US20050137691A1 (en) 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US20050137694A1 (en) 2003-12-23 2005-06-23 Haug Ulrich R. Methods and apparatus for endovascularly replacing a patient's heart valve
US20050149181A1 (en) 2004-01-07 2005-07-07 Medtronic, Inc. Bileaflet prosthetic valve and method of manufacture
US20050159810A1 (en) 2004-01-15 2005-07-21 Farzan Filsoufi Devices and methods for repairing cardiac valves
WO2005069850A2 (en) 2004-01-15 2005-08-04 Macoviak John A Trestle heart valve replacement
US7488346B2 (en) 2004-01-21 2009-02-10 The Cleveland Clinic Foundation Method and apparatus for replacing a mitral valve and an aortic valve with a single homograft
JP4494421B2 (en) 2004-01-22 2010-06-30 アドヴァンスト サージカル デザイン アンド マニュファクチャー リミテッド Heart valves
US7320705B2 (en) 2004-01-23 2008-01-22 James Quintessenza Bicuspid pulmonary heart valve and method for making same
US7871435B2 (en) 2004-01-23 2011-01-18 Edwards Lifesciences Corporation Anatomically approximate prosthetic mitral heart valve
US7597711B2 (en) 2004-01-26 2009-10-06 Arbor Surgical Technologies, Inc. Heart valve assembly with slidable coupling connections
AT455520T (en) 2004-01-27 2010-02-15 Med Inst Inc Barbs for mounting to a medical prosthesis
US7470285B2 (en) 2004-02-05 2008-12-30 Children's Medical Center Corp. Transcatheter delivery of a replacement heart valve
US20050182483A1 (en) 2004-02-11 2005-08-18 Cook Incorporated Percutaneously placed prosthesis with thromboresistant valve portion
US7311730B2 (en) 2004-02-13 2007-12-25 Shlomo Gabbay Support apparatus and heart valve prosthesis for sutureless implantation
US7955375B2 (en) 2004-02-20 2011-06-07 Cook Medical Technologies Llc Prosthetic valve with spacing member
CA2557657C (en) 2004-02-27 2013-06-18 Aortx, Inc. Prosthetic heart valve delivery systems and methods
US7717930B2 (en) 2004-02-27 2010-05-18 Cook Incorporated Valvulotome with a cutting edge
US7395130B2 (en) 2004-02-27 2008-07-01 Micron Technology, Inc. Method and system for aggregating and combining manufacturing data for analysis
WO2005086888A2 (en) 2004-03-09 2005-09-22 Fidel Realyvasquez Off pump aortic valve replacement for valve prosthesis
AU2005221234C1 (en) 2004-03-11 2009-10-29 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous heart valve prosthesis
EP1734898A1 (en) 2004-03-15 2006-12-27 Medtronic Vascular, Inc. Radially crush-resistant stent
WO2005087139A1 (en) 2004-03-15 2005-09-22 Baker Medical Research Institute Treating valve failure
US20050228494A1 (en) 2004-03-29 2005-10-13 Salvador Marquez Controlled separation heart valve frame
US7449027B2 (en) 2004-03-29 2008-11-11 Cook Incorporated Modifying fluid flow in a body vessel lumen to promote intraluminal flow-sensitive processes
US7993397B2 (en) 2004-04-05 2011-08-09 Edwards Lifesciences Ag Remotely adjustable coronary sinus implant
US20050222675A1 (en) 2004-04-06 2005-10-06 Sauter Joseph A Implantable prosthetic heart valve comprising a valve body and a tubular vascular graft
US8349001B2 (en) 2004-04-07 2013-01-08 Medtronic, Inc. Pharmacological delivery implement for use with cardiac repair devices
EP1737390A1 (en) 2004-04-08 2007-01-03 Cook Incorporated Implantable medical device with optimized shape
WO2005099628A2 (en) 2004-04-13 2005-10-27 Cook Incorporated Implantable frame with variable compliance
US20050240202A1 (en) 2004-04-21 2005-10-27 Hani Shennib Devices and methods of repairing cardiac valves
US10219899B2 (en) 2004-04-23 2019-03-05 Medtronic 3F Therapeutics, Inc. Cardiac valve replacement systems
US7641686B2 (en) 2004-04-23 2010-01-05 Direct Flow Medical, Inc. Percutaneous heart valve with stentless support
US7951196B2 (en) 2004-04-29 2011-05-31 Edwards Lifesciences Corporation Annuloplasty ring for mitral valve prolapse
US20050244460A1 (en) 2004-04-29 2005-11-03 Ivan Alferiev Biodegradable crosslinking strategies using triglycidyl amine (TGA)
US20050256566A1 (en) 2004-05-03 2005-11-17 Shlomo Gabbay Apparatus and method for improving ventricular function
US7374573B2 (en) 2004-05-03 2008-05-20 Shlomo Gabbay System and method for improving ventricular function
US7717951B2 (en) 2004-05-06 2010-05-18 Cook Incorporated Delivery system that facilitates visual inspection of an intraluminal medical device
US20060095115A1 (en) 2004-05-10 2006-05-04 Youssef Bladillah Stent and method of manufacturing same
US20060122692A1 (en) 2004-05-10 2006-06-08 Ran Gilad Stent valve and method of using same
US20060122693A1 (en) 2004-05-10 2006-06-08 Youssef Biadillah Stent valve and method of manufacturing same
US20060122686A1 (en) 2004-05-10 2006-06-08 Ran Gilad Stent and method of manufacturing same
WO2005112831A2 (en) 2004-05-17 2005-12-01 Fidel Realyvasquez Method and apparatus for percutaneous valve repair
US7785615B2 (en) 2004-05-28 2010-08-31 Cordis Corporation Biodegradable medical implant with encapsulated buffering agent
US7803182B2 (en) 2004-05-28 2010-09-28 Cordis Corporation Biodegradable vascular device with buffering agent
US7780725B2 (en) 2004-06-16 2010-08-24 Sadra Medical, Inc. Everting heart valve
GB0414099D0 (en) 2004-06-23 2004-07-28 Univ Glasgow Biocompatible layered structures and methods for their manufacture
US7361190B2 (en) 2004-06-29 2008-04-22 Micardia Corporation Adjustable cardiac valve implant with coupling mechanism
EP2982337A1 (en) 2004-06-30 2016-02-10 Edwards Lifesciences PVT, Inc. Paravalvular leak detection, sealing, and prevention
EP1781179A1 (en) 2004-07-06 2007-05-09 Baker Medical Research Institute Treating valvular insufficiency
US7422607B2 (en) 2004-08-24 2008-09-09 Oviatt Henry W Anti-calcification treatments for heart valves and vascular grafts
AU2005280151A1 (en) 2004-08-26 2006-03-09 Cook Incorporated Delivery system with controlled frictional properties
WO2006026371A1 (en) 2004-08-27 2006-03-09 Cook Incorporated Placement of multiple intraluminal medical devices within a body vessel
AU2005282871B2 (en) 2004-09-01 2010-08-26 Cook Medical Technologies Llc Delivery system which facilitates hydration of an intraluminal medical device
US7566343B2 (en) 2004-09-02 2009-07-28 Boston Scientific Scimed, Inc. Cardiac valve, system, and method
FR2874813B1 (en) 2004-09-07 2007-06-22 Perouse Soc Par Actions Simpli valvular prosthesis
US20060052867A1 (en) 2004-09-07 2006-03-09 Medtronic, Inc Replacement prosthetic heart valve, system and method of implant
CN1745727A (en) 2004-09-08 2006-03-15 王蓉珍 Intercurrent artificial heart valve, its implanting and recovering device
AU2005285314B2 (en) 2004-09-10 2010-10-14 Cook Medical Technologies Llc Prosthetic valve with pores
CN101056596B (en) 2004-09-14 2011-08-03 爱德华兹生命科学股份公司 Device and method for treatment of heart valve regurgitation
US20060064174A1 (en) 2004-09-22 2006-03-23 Reza Zadno Implantable valves and methods of making the same
US7850704B2 (en) 2004-09-27 2010-12-14 Theranova, Llc Method and apparatus for anchoring implants
US6951571B1 (en) 2004-09-30 2005-10-04 Rohit Srivastava Valve implanting device
US20060074483A1 (en) 2004-10-01 2006-04-06 Schrayer Howard L Method of treatment and devices for the treatment of left ventricular failure
JP2008514345A (en) 2004-10-02 2008-05-08 クリストフ・ハンス・フーバー Apparatus for treating or replacing a heart valve or surrounding tissue without the need for full support of cardiopulmonary
US7544207B2 (en) 2004-10-06 2009-06-09 Cook Incorporated Medical device with bioactive agent
US20060085060A1 (en) 2004-10-15 2006-04-20 Campbell Louis A Methods and apparatus for coupling an allograft tissue valve and graft
WO2006050459A2 (en) 2004-10-28 2006-05-11 Cook Incorporated Methods and systems for modifying vascular valves
US7458987B2 (en) 2004-10-29 2008-12-02 Cook Incorporated Vascular valves having implanted and target configurations and methods of preparing the same
US7641687B2 (en) 2004-11-02 2010-01-05 Carbomedics Inc. Attachment of a sewing cuff to a heart valve
US20060100697A1 (en) 2004-11-10 2006-05-11 Casanova R M Shape memory annuloplasty ring and holder
US20060167468A1 (en) 2004-11-12 2006-07-27 Shlomo Gabbay Implantation system and method for loading an implanter with a prosthesis
KR20070094888A (en) 2004-11-19 2007-09-27 메드트로닉 인코포레이티드 Method and apparatus for treatment of cardiac valves
US7744642B2 (en) 2004-11-19 2010-06-29 Biomedical Research Associates, Inc. Prosthetic venous valves
US20060135967A1 (en) 2004-11-22 2006-06-22 Fidel Realyvasquez Method and apparatus for attaching a valve prosthesis
US20060161249A1 (en) 2004-11-22 2006-07-20 Fidel Realyvasquez Ring-shaped valve prosthesis attachment device
US20060111774A1 (en) 2004-11-24 2006-05-25 Samkov Alexander V Low noise heart valve prosthesis and method for operation
WO2006060546A2 (en) 2004-12-01 2006-06-08 Cook Incorporated Valve with leak path
WO2006073628A1 (en) 2004-12-01 2006-07-13 Cook Incorporated Sensing delivery system for intraluminal medical devices
CA2589355A1 (en) 2004-12-06 2005-12-06 Surmodics, Inc. Multifunctional medical articles
WO2006063199A2 (en) 2004-12-09 2006-06-15 The Foundry, Inc. Aortic valve repair
US7211110B2 (en) 2004-12-09 2007-05-01 Edwards Lifesciences Corporation Diagnostic kit to assist with heart valve annulus adjustment
US20060127443A1 (en) 2004-12-09 2006-06-15 Helmus Michael N Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery
US7410497B2 (en) 2004-12-14 2008-08-12 Boston Scientific Scimed, Inc. Stimulation of cell growth at implant surfaces
IE20050841A1 (en) 2004-12-15 2006-10-04 Mednua Ltd A medical device suitable for use in treatment of a valve
SE0403046D0 (en) 2004-12-15 2004-12-15 Medtentia Ab A device and method for Improving the function of a heart valve
EP1830748A4 (en) 2004-12-16 2008-06-04 Carlos Ruiz A heart valve and method for insertion of the heart valve into a bodily vessel
US20060217794A1 (en) 2004-12-16 2006-09-28 Carlos Ruiz Separable sheath and method for insertion of a medical device into a bodily vessel using a separable sheath
US7758640B2 (en) 2004-12-16 2010-07-20 Valvexchange Inc. Cardiovascular valve assembly
US7544205B2 (en) 2004-12-20 2009-06-09 Cook Incorporated Intraluminal support frame and medical devices including the support frame
US7575594B2 (en) 2004-12-30 2009-08-18 Sieracki Jeffrey M Shock dampening biocompatible valve
DE102005003632A1 (en) 2005-01-20 2006-08-17 Ferrari, Markus, Dr.med. Dr.disc.pol. Catheter for trans-vascular implantation of prosthetic heart valves
US7914569B2 (en) * 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
ES2441801T3 (en) 2007-02-05 2014-02-06 Boston Scientific Limited Percutaneous valve and delivery system

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994077A (en) * 1989-04-21 1991-02-19 Dobben Richard L Artificial heart valve for implantation in a blood vessel
US5713953A (en) * 1991-05-24 1998-02-03 Sorin Biomedica Cardio S.P.A. Cardiac valve prosthesis particularly for replacement of the aortic valve
US6010531A (en) * 1993-02-22 2000-01-04 Heartport, Inc. Less-invasive devices and methods for cardiac valve surgery
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US6673109B2 (en) * 1993-11-01 2004-01-06 3F Therapeutics, Inc. Replacement atrioventricular heart valve
US20040030405A1 (en) * 1994-07-29 2004-02-12 Sophie Carpentier Methods for treating implantable biological tissues to mitigate the calcification thereof and bioprosthetic articles treated by such methods
US5716370A (en) * 1996-02-23 1998-02-10 Williamson, Iv; Warren Means for replacing a heart valve in a minimally invasive manner
US20060041305A1 (en) * 1996-06-20 2006-02-23 Karl-Lutz Lauterjung Prosthetic repair of body passages
US20040015230A1 (en) * 1996-12-18 2004-01-22 Moll Franciscus Laurens Methods for regulating the flow of blood through the blood system
US20060009842A1 (en) * 1997-03-27 2006-01-12 Huynh Van L Contoured heart valve suture rings
US6837902B2 (en) * 1997-04-03 2005-01-04 Edwards Lifesciences Corporation Methods of making bioprosthetic heart valves with strain matched leaflets
US20040002719A1 (en) * 1997-06-27 2004-01-01 Oz Mehmet C. Method and apparatus for circulatory valve repair
US20050004583A1 (en) * 1997-06-27 2005-01-06 Oz Mehmet C. Method and apparatus for circulatory valve repair
US6508833B2 (en) * 1998-06-02 2003-01-21 Cook Incorporated Multiple-sided intraluminal medical device
US6695866B1 (en) * 1998-07-15 2004-02-24 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US6692512B2 (en) * 1998-10-13 2004-02-17 Edwards Lifesciences Corporation Percutaneous filtration catheter for valve repair surgery and methods of use
US20060013805A1 (en) * 1998-11-24 2006-01-19 Regents Of The University Of Minnesota Transgenic circulating endothelial cells
US6846324B2 (en) * 1999-01-26 2005-01-25 Edwards Lifesciences Corporation Combination anatomical orifice sizer and heart valve
US20050010285A1 (en) * 1999-01-27 2005-01-13 Lambrecht Gregory H. Cardiac valve procedure methods and devices
US20040003819A1 (en) * 1999-04-09 2004-01-08 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20040039442A1 (en) * 1999-04-09 2004-02-26 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20050033446A1 (en) * 1999-04-09 2005-02-10 Evalve, Inc. A California Corporation Methods and apparatus for cardiac valve repair
US20050021056A1 (en) * 1999-04-09 2005-01-27 Evalve, Inc. Leaflet structuring
US20040030382A1 (en) * 1999-04-09 2004-02-12 Evalve, Inc. Methods and apparatus for cardiac valve repair
US20020013571A1 (en) * 1999-04-09 2002-01-31 Evalve, Inc. Methods and devices for capturing and fixing leaflets in valve repair
US20060020275A1 (en) * 1999-04-09 2006-01-26 Evalve, Inc. Locking mechanisms for fixation devices and methods of engaging tissue
US20050043792A1 (en) * 1999-06-29 2005-02-24 Edwards Lifesciences Ag Device and method for treatment of mitral insufficiency
US20040039443A1 (en) * 1999-06-30 2004-02-26 Solem Jan Otto Method and device for treatment of mitral insufficiency
US20020026216A1 (en) * 1999-10-13 2002-02-28 Grimes Randall Y. Devices and methods for percutaneous mitral valve repair
US6685739B2 (en) * 1999-10-21 2004-02-03 Scimed Life Systems, Inc. Implantable prosthetic valve
US6840957B2 (en) * 1999-10-21 2005-01-11 Scimed Life Systems, Inc. Implantable prosthetic valve
US20060000715A1 (en) * 2000-01-25 2006-01-05 Whitcher Forrest D Manufacturing medical devices by vapor deposition
US20050015112A1 (en) * 2000-01-27 2005-01-20 Cohn William E. Cardiac valve procedure methods and devices
US6682559B2 (en) * 2000-01-27 2004-01-27 3F Therapeutics, Inc. Prosthetic heart valve
US6989028B2 (en) * 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US20040024447A1 (en) * 2000-04-27 2004-02-05 Axel Haverich Individual venous valve prosthesis
US6840246B2 (en) * 2000-06-20 2005-01-11 University Of Maryland, Baltimore Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart
US6695878B2 (en) * 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US6676698B2 (en) * 2000-06-26 2004-01-13 Rex Medicol, L.P. Vascular device with valve for approximating vessel wall
US20040030321A1 (en) * 2000-07-11 2004-02-12 Fangrow Thomas F. Medical valve with positive flow characteristics
US6846325B2 (en) * 2000-09-07 2005-01-25 Viacor, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US20050010287A1 (en) * 2000-09-20 2005-01-13 Ample Medical, Inc. Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet
US20040015233A1 (en) * 2000-10-09 2004-01-22 Josef Jansen Cardiac valve prosthesis, especially mitral cardiac valve and method for producing the same
US20060025856A1 (en) * 2001-03-15 2006-02-02 Medtronic, Inc. Annuloplasty band and method
US6503272B2 (en) * 2001-03-21 2003-01-07 Cordis Corporation Stent-based venous valves
US20040019378A1 (en) * 2001-04-24 2004-01-29 Hlavka Edwin J. Method and apparatus for performing catheter-based annuloplasty
US6682558B2 (en) * 2001-05-10 2004-01-27 3F Therapeutics, Inc. Delivery system for a stentless valve bioprosthesis
US6676702B2 (en) * 2001-05-14 2004-01-13 Cardiac Dimensions, Inc. Mitral valve therapy assembly and method
US20050033419A1 (en) * 2001-05-14 2005-02-10 Alferness Clifton A. Mitral valve therapy device, system and method
US20050027353A1 (en) * 2001-05-14 2005-02-03 Alferness Clifton A. Mitral valve therapy device, system and method
US20050038507A1 (en) * 2001-05-14 2005-02-17 Alferness Clifton A. Mitral valve therapy device, system and method
US20050027351A1 (en) * 2001-05-14 2005-02-03 Cardiac Dimensions, Inc. A Washington Corporation Mitral valve regurgitation treatment device and method
US20040034380A1 (en) * 2001-06-29 2004-02-19 Woolfson Steven B. Method and apparatus for resecting and replacing an aortic valve
US20050043790A1 (en) * 2001-07-04 2005-02-24 Jacques Seguin Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body
US20050033398A1 (en) * 2001-07-31 2005-02-10 Jacques Seguin Assembly for setting a valve prosthesis in a corporeal duct
US6842226B2 (en) * 2001-09-21 2005-01-11 Nikon Corporation Flexure supported wafer table
US20040039436A1 (en) * 2001-10-11 2004-02-26 Benjamin Spenser Implantable prosthetic valve
US20060020336A1 (en) * 2001-10-23 2006-01-26 Liddicoat John R Automated annular plication for mitral valve repair
US20040010305A1 (en) * 2001-12-05 2004-01-15 Cardiac Dimensions, Inc. Device and method for modifying the shape of a body organ
US20040024451A1 (en) * 2002-01-02 2004-02-05 Medtronic, Inc. Prosthetic heart valve system
US20060041306A1 (en) * 2002-01-09 2006-02-23 Myocor, Inc. Devices and methods for heart valve treatment
US20040019377A1 (en) * 2002-01-14 2004-01-29 Taylor Daniel C. Method and apparatus for reducing mitral regurgitation
US20060030882A1 (en) * 2002-03-06 2006-02-09 Adams John M Transvenous staples, assembly and method for mitral valve repair
US20050021136A1 (en) * 2002-03-21 2005-01-27 Hua Xie Method for suturelessly attaching a biomaterial to an implantable bioprosthesis frame
US20060030866A1 (en) * 2002-03-26 2006-02-09 Stefan Schreck Sequential heart valve leaflet repair device and method of use
US20040019374A1 (en) * 2002-05-10 2004-01-29 Hikmat Hojeibane Frame based unidirectional flow prosthetic implant
US6986775B2 (en) * 2002-06-13 2006-01-17 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US20060025750A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060025787A1 (en) * 2002-06-13 2006-02-02 Guided Delivery Systems, Inc. Devices and methods for heart valve repair
US6858039B2 (en) * 2002-07-08 2005-02-22 Edwards Lifesciences Corporation Mitral valve annuloplasty ring having a posterior bow
US20040015232A1 (en) * 2002-07-16 2004-01-22 Medtronic, Inc. Suturing rings for implantable heart valve prosthesis
US20040030381A1 (en) * 2002-07-16 2004-02-12 Shu Mark C.S. Heart valve prosthesis
US20040024452A1 (en) * 2002-08-02 2004-02-05 Kruse Steven D. Valved prostheses with preformed tissue leaflets
US20040034411A1 (en) * 2002-08-16 2004-02-19 Quijano Rodolfo C. Percutaneously delivered heart valve and delivery means thereof
US20060015136A1 (en) * 2002-09-19 2006-01-19 Memory Metal Holland Bv Vascular filter with improved strength and flexibility
US20060030885A1 (en) * 2002-10-15 2006-02-09 Hyde Gregory M Apparatuses and methods for heart valve repair
US20060036317A1 (en) * 2002-11-12 2006-02-16 Myocor, Inc. Decives and methods for heart valve treatment
US20050038506A1 (en) * 2002-11-15 2005-02-17 Webler William E. Apparatuses and methods for heart valve repair
US20060020335A1 (en) * 2002-12-26 2006-01-26 Leonard Kowalsky System and method to effect the mitral valve annulus of a heart
US6997950B2 (en) * 2003-01-16 2006-02-14 Chawla Surendra K Valve repair device
US6989027B2 (en) * 2003-04-30 2006-01-24 Medtronic Vascular Inc. Percutaneously delivered temporary valve assembly
US20060009841A1 (en) * 2003-05-05 2006-01-12 Rex Medical Percutaneous aortic valve
US20050004667A1 (en) * 2003-06-05 2005-01-06 Cardiac Dimensions, Inc. A Delaware Corporation Device, system and method to affect the mitral valve annulus of a heart
US20050027261A1 (en) * 2003-07-30 2005-02-03 Karla Weaver Pressure actuated valve with improved slit configuration
US20050027348A1 (en) * 2003-07-31 2005-02-03 Case Brian C. Prosthetic valve devices and methods of making such devices
US20060025784A1 (en) * 2003-09-04 2006-02-02 Guided Delivery Systems, Inc. Delivery devices and methods for heart valve repair
US20060013855A1 (en) * 2004-04-05 2006-01-19 Medivas, Llc Bioactive stents for type II diabetics and methods for use thereof
US20060025857A1 (en) * 2004-04-23 2006-02-02 Bjarne Bergheim Implantable prosthetic valve
US20060020334A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Methods of cardiac valve replacement using nonstented prosthetic valve
US20060020327A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented heart valves with formed in situ support
US20060025855A1 (en) * 2004-05-05 2006-02-02 Lashinski Randall T Translumenally implantable heart valve with multiple chamber formed in place support
US20060020332A1 (en) * 2004-05-05 2006-01-26 Lashinski Randall T Nonstented temporary valve for cardiovascular therapy
US20060025854A1 (en) * 2004-05-05 2006-02-02 Lashinski Randall T Translumenally implantable heart valve with formed in place support
US20060004442A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Paravalvular leak detection, sealing, and prevention
US20060004439A1 (en) * 2004-06-30 2006-01-05 Benjamin Spenser Device and method for assisting in the implantation of a prosthetic valve
US20060030747A1 (en) * 2004-07-09 2006-02-09 Kantrowitz Allen B Synchronization system between aortic valve and cardiac assist device
US20060009804A1 (en) * 2004-07-12 2006-01-12 Pederson Brian D Anti-coagulation and demineralization system for conductive medical devices
US20060015178A1 (en) * 2004-07-15 2006-01-19 Shahram Moaddeb Implants and methods for reshaping heart valves
US20060015179A1 (en) * 2004-07-19 2006-01-19 Neil Bulman-Fleming Aortic annuloplasty ring

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060259115A1 (en) * 2005-05-13 2006-11-16 Case Brian C Medical device delivery systems that facilitate medical device placement in the presence of ultrasonic waves
US20060271064A1 (en) * 2005-05-24 2006-11-30 Agnew Charles W Medical device delivery system with captive inner member
US8043352B2 (en) 2005-05-24 2011-10-25 Cook Medical Technologies Llc Medical device delivery system with captive inner member
US20070167745A1 (en) * 2005-12-29 2007-07-19 Cook Incorporated Methods for delivering medical devices to a target implant site within a body vessel
US20070288087A1 (en) * 2006-05-30 2007-12-13 Cook Incorporated Artificial valve prosthesis
US8038710B2 (en) * 2006-05-30 2011-10-18 Cook Medical Technologies Llc Artificial valve prosthesis
US20090248142A1 (en) * 2008-03-25 2009-10-01 Medtronic Vascular, Inc. Methods, Devices and Systems for Treating Venous Insufficiency
US9770333B2 (en) 2008-03-25 2017-09-26 Medtronic Vascular, Inc. Methods, devices and systems for treating venous insufficiency
US20100217385A1 (en) * 2009-02-24 2010-08-26 Medtronic Vascular, Inc. One-Way Replacement Valve
US8348997B2 (en) 2009-02-24 2013-01-08 Medtronic Vascular, Inc. One-way replacement valve
US20110033933A1 (en) * 2009-07-15 2011-02-10 Morteza Gharib Method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves
WO2012015825A3 (en) * 2010-07-27 2012-04-19 Incept, Llc Methods and apparatus for treating neurovascular venous outflow obstruction
US20150164642A1 (en) * 2010-07-27 2015-06-18 Fred Khosravi Methods and apparatus for treating neurovascular venous outflow obstruction
US9675457B2 (en) * 2010-07-27 2017-06-13 Incept, Llc Methods and apparatus for treating neurovascular venous outflow obstruction
US20170156863A1 (en) * 2015-12-03 2017-06-08 Medtronic Vascular, Inc. Venous valve prostheses
US10143554B2 (en) * 2015-12-03 2018-12-04 Medtronic Vascular, Inc. Venous valve prostheses

Also Published As

Publication number Publication date
US7951189B2 (en) 2011-05-31
EP1945141B1 (en) 2017-10-25
US20070067021A1 (en) 2007-03-22
US20120209378A1 (en) 2012-08-16
US8460365B2 (en) 2013-06-11
US9474609B2 (en) 2016-10-25
US20100005658A1 (en) 2010-01-14
CA2623321C (en) 2014-09-16
EP1945141A2 (en) 2008-07-23
WO2007038047A2 (en) 2007-04-05
US20160022421A1 (en) 2016-01-28
US20130274865A1 (en) 2013-10-17
US20170020672A1 (en) 2017-01-26
CA2623321A1 (en) 2007-04-05
WO2007038047A3 (en) 2008-08-21
US7569071B2 (en) 2009-08-04
US8672997B2 (en) 2014-03-18
US20110230949A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
US6989027B2 (en) Percutaneously delivered temporary valve assembly
AU2006251888B2 (en) Apparatus and methods for repairing the function of a diseased valve and method for making same
US8080054B2 (en) Implantable prosthetic valve with non-laminar flow
EP2111190B1 (en) Stented heart valve devices for atrioventricular valve replacement
US7351256B2 (en) Frame based unidirectional flow prosthetic implant
EP2254512B1 (en) Markers for prosthetic heart valves
US8663541B2 (en) Method of forming a tubular membrane on a structural frame
EP1977719B1 (en) Method of forming an implantable prosthetic valve
US7485141B2 (en) Method of placing a tubular membrane on a structural frame
EP1667604B1 (en) Frame based unidirectional flow prosthetic implant
KR101616138B1 (en) Infundibular reducer devices
EP2282700B1 (en) Stented heart valve devices
US6951571B1 (en) Valve implanting device
US8075611B2 (en) Stented prosthetic heart valves
US8470022B2 (en) Implantable valve
US7717952B2 (en) Artificial prostheses with preferred geometries
US10154902B2 (en) Infundibular reducer device delivery system and related methods
EP2273947B1 (en) Self cleaning devices and systems
US7261732B2 (en) Stent mounted valve
EP2830535B1 (en) Dual valve prosthesis for transcatheter valve implantation
US8721717B2 (en) Venous valve apparatus, system, and method
DK2254514T3 (en) Stents for heart valve prostheses
US8070800B2 (en) Transcatheter heart valve prostheses
US7195641B2 (en) Valvular prostheses having metal or pseudometallic construction and methods of manufacture
CN101951857B (en) Percutaneous heart valve, system, and method

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DRASLER, WILLIAM J.;JENSON, MARK L.;HILL, JASON P.;AND OTHERS;REEL/FRAME:018793/0437;SIGNING DATES FROM 20070102 TO 20070105